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ABSTRACT
The lipotropic and hypolipidemic effects of carnitine and its
precursors, namely lysine (Lys) and methionine (Met), was examined in
male Sprague-Dawley rats fed ethanol as 36% of the total calories
for a duration of 56 days (Experiment I).

Ethanol produced significant

hepatic steatosis and hypertriglyceridemia as evidenced from elevated
concentrations of total lipids, triglycerides, cholesterols, and
phospholipids.

Supplementation of the ethanol diet with 1.0%

D,L-carnitine and 0.5% L-Lys plus 0.2% L-Met significantly reduced
ethanol-induced elevation of the various lipid classes with the
exception of free fatty acids.

The triglyceride contents in liver

and plasma were inver~ely related to the concentrations of carnitine,
acylcarnitines, and total carnitine.

The effects of a combination

of carnitin~ and its precursors were not greater than those of
carnitine alone.

It is suggested, therefore, that a deficiency of

functional carnitine may exist in a chronic alcoholic state which
can be improved by dietary carnitine.
In two following experiments, animals were fed the ethanol
liquid diets supplemented with various levels (Experiment II:
0.2, 0.6, 1.0, and 2.0%; Experiment III:

0.0,

0.0, 0.1, 0.5, 0.8, 1.2,

and 1.6%) of D,L-carnitine for 28 and 45 days.

In the 28 day

experiment, the effects of supplemental carnitine were significant
only in the plasma triglycerides and reduction in hepatic lipid
classes were minimal.

In the 45 day experiment, various lipid
iii
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classes of the alcohol-compromised liver and plasma were significantly
reduced with carnitine treatment, and the effect was dose-dependent.
The optimum lipotropic and hypolipidemic effect were produced by
0.8% D,L-carnitir.e.

Thus, it is concluded that in rats, supplemental

D,L-carnitine ameliorated ethanol-induced hyperlipidemia and hepatic
steatosis in a dose-dependent manner.
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CHAPTER I
INTRODUCTION
Alcoholism and alcohol abuse are major health problems.

In

the United States, cirrhosis of the liver is the fifth leading cause
of death in the general population (1).

The mechanism of the

variable response to ethanol intake remains unclear, and the
relationship of liver damage to alcohol metabolism is controversial.
Although a great deal of evidence has been gathered to explain an
etiological role of ethanol in the pathogenesis of the ethanolinduced disorders, other factors associated with alcohol abuse also
play important roles.
Research interest has been centered around the relationship
of ethanol intake to nutrition and lipid metabolism.

Many excellent

reviews are available which deal with the metabolic interrelationships
of ethanol (2), nutrition (3), lipid (4), carbohydrate (5), and
intermediary metabolism (2,5).

Lately, with the realization that

ethanol may exert its own influence by acting as a direct hepatotoxin,
research interest has shifted to other areas, especially those
concerned with macromolecular metabolism within the hepatocyte (6-9).
Chronic ingestion of ethanol has been reported to cause
hepatic steatosis in experimental animals (10-14) as well as in
humans (12-14).

Primary attention has been usually given to the

effects of ethanol on triglycerides, which make up the major
class of hepatic lipids.

However, significant effects on
1
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cholesterol esters (10-15), phospholipids (11,15) and lipoproteins
(16) have also been reported.

Since ethanol is obligately metabolized

in the liver (17), hepatic steatosis and associated hyperlipidemia
are common features of disturbed lipid metabolism caused by ethanol
intake.
Despite considerable research efforts, no satisfactory
treatment for ethanol-induced fatty liver has yet been found.

Many

groups of investigators have studied the effectiveness of various
dietary or nondietary chemical agents in preventing ethanol-induced
fatty liver, but the results have not been entirely satisfactory.
These studies have recently been reviewed (18).

Most research for

prevention of ethanol-induced disorders has been confined to fatty
liver since this was the only disorder reproducible in an animal,
and its mechanism was partly understood.

Choline supplements

protected rats, but not humans, against ethanol-induced fatty liver
(19).

Many drugs, including clofibrate (20), asparagine and

barbiturate (21) have been credited as .inhibitors against ethanolinduced fatty liver in rats, but these drugs were usually tested
against a single large dose of ethanol intake.

Recently in rats,

a marked protective benefit of a combination of naturally occurring
substances including riboflavin, dihydroxyacetone, and pyruvate
has been reported (22).

These agents have a potential to accept

hydrogen ions and hence can correct the altered redox state of the
alcoholic liver.

3

Among the dietary agents, the effect of dietary carnitine(3hydroxy-4-N-trimethylaminobutyrate) has been found controversial.
Some investigators suggested a state of carnitine deficiency in
animals (23) and in patients hospitalized for alcoholic cirrhosis
of liver (24), whereas others (25,26) demonstrated that ethanolinduced liver injury is not related to carnitine deficiency.

The

argument for a deficiency of carnitine in ethanol-induced fatty
liver is based on the fact that carnitine is known to enhance fat
metabolism by facilitating the transport of fatty acids (FA) into
mitochondria where the oxidation of FA occurs.

Indeed, carnitine

is required for the efficient oxidation of FA (27-29).

Thus, the

oxidation of FA might be depressed in various organs in the absence
of carnitine.

Unfortunately, only three or four studies (23,24,30)

have been carried out on the relationship between exogenous carnitine
and ethanol-induced disturbances of lipid metabolism.
The objectives of this study were:
1.

to determine effects of carnitine on ethanol-induced
hyperlipemia and hepatic steatosis;

2.

to establish dose dependent relationship between
supplemental carnitine and lipotropy;

3.

to assess the potential of alcoholic liver for
biosynthesis of carnitine from its presursors.

CHAPTER II
REVIEW OF LITERATURE
1.

ETHANOL METABOLISM

Ethanol is preferentially metabolized by the liver via the
following reactions:
(A)

CH3CH20H + NAO+

ADH

(B)

CH3CH20H + NAOPH + H+ + 02

>

CH3CHO + NAOH + H+
MEOS

>

CH3CHO + NAOP+

+ 2H20
(C)

CH3CH20H + H202

(O)

cH 3CHO + NAO+

Catalase

>

CH3CHO + 2H20

aldehyde dehydrogenase

>

CH 3COOH +

NAOH + H+
Reaction A involves the cytosolic enzyme, alcohol dehydrogenase
(AOH) with nicotinamide adenine dinucleotide (NAO) as a cofactor.
This reaction results in the formation of acetaldehyde and the
reduction of NAO to NADH + H+.

As a result, oxidation of ethanol

generates an excess of reducing equivalents in the liver primarily
as NAOH+H+ (31).

Ethanol is also oxidized by an alternative path-

way (reaction B) that requires NADPH (reduced nicotinamide adenine
dinucleotide phosphate) as a cofactor which is localized in the
endoplasmic reticulum (32).

Unlike AOH, the activity of microsomal

ethanol oxidizing system (MEOS) increases during chronic ethanol
4
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consumption (33).

There is also an argument for a possible role

of catalase (reaction C) in the oxidation of ethanol to acetaldehyde
(34).

However, it is generally considered that under normal

conditions ethanol oxidation proceeds primarily by the alcohol
dehydrogenase pathway.

Acetaldehyde, the first oxidation product

of ethanol, is further oxidized to acetate (reaction D) by aldehyde
dehydrogenase (35).

Although liver can readily metabolize acetate

in vitro, most of acetate is utilized, in vivo, by extrahepatic
tissues (36).

The oxidative metabolic pathway of ethanol and the

consequence of metabolic burden are illustrated in Figure 1 (2).
Ethanol is readily absorbed from the gastrointestinal tract.
Only 2-10% of the amount absorbed is eliminated through kidney and
lungs.

Thus, the bulk of ethanol, which has high caloric value

(7.1 kcal/g), is oxidized in the liver (12).

This organ specificity

of ethanol metabolism is further aggravated by the absence of a
storage and feedback mechanism (12).

Consequently, the oxidation of

ethanol produces considerable metabolic imbalances in the liver.
2.

GENERAL METABOLIC EFFECTS

Many of the metabolic derangements in the liver caused by
ethanol consumption seem to be attributable to the products of
ethanol oxidation or its metabolites such as acetaldehyde and
acetate.

Most of the metabolic consequences of ethanol metabolism

can be attributed to the generation of excess reducing equivalents
(increased NADH + H+/NAD ratio) or to the formation of acetaldehyde,

6
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an extremely reactive metabolite.

Although large amounts of acetate

are formed from acetaldehyde during ethanol oxidation, its effect
on .hepatic metabolism has remained unknown.

Little was known about

blooj acetaldehyde concentrations in subjects consuming ethanol
until Karsten et al. (37) reported a difference in blood acetaldehyde
concentrations between alcoholic and nonalcoholic subjects after
ethanol administration.

The increased rate of ethanol oxidation

that followed prolonged ethanol consumption resulted in increased
acetaldehyde concentrations in alcoholics compared to nonalcoholics
(42.7 .:!:. 1.2 vs 26.5 + 1.5 µmoles) (37).

The rate of oxidation of

acetaldehyde in the mitochondria does not parallel the increased
rate of ethanol oxidation to acetaldehyde (38).

Consequently high

acetaldehyde content may exert its own toxic effect since acetaldehyde
is a very reactive compound.

During ethanol oxidation, the rate

of oxidation of acetate in the liver is decreased because of the
inhibition of the citric acid cycle (39.40).

The activity of the

citric acid cycle is depressed partly because of a retardation of
the reactions of the cycle that requires NAO.

A major site of this

interaction of ethanol in the citric acid cycle is at the
a-ketoglutarate oxidation step (41).

Furthermore, the redox change

associated with ethanol oxidation decreases the hepatic
concentration of oxaloacetate (42).

The concentrations of

oxaloacetate is important for the efficient synthesis of citrate.
The ultimate consequences of abnormal generation of acetate from
ethanol in the liver remain unknown.

It was also reported that

8

ethanol intake causes proliferation of the smooth membranes of the
hepatic endoplasmic reticulum (43).
Since ethanol is exclusively metabolized in the liver, a
stressful metabolic burden is imposed on the liver whenever
significantly large quantities of ethanol are consumed.

Generally

much of the metabolic disturbance caused by ethanol intake is
attributed to the generation of excess reducing equivalents in the
liver and the attempts of the liver to correct this abnormal
redox state.
3.

SPECIFIC METABOLIC EFFECTS

Effects of Excessive Hepatic NAOH Generation
The oxidation of ethanol results in the transfer of hydrogen
to NAO+.

The resulting increased NAOH + H+/NAO+ ratio produces

a change in the proportion of metabolites that are dependent on
the availabilities of NAO+ and is responsible for a number of
metabolic abnormalities associated witb alcohol abuse.
Some of the metabolic abnormalities associated with ethanol
intake are summarized below.

The enhanced NADH + H+/NAO+ ratio

induces an increased lactate/pyruvate ratio that results in
hyperlactacidemia (44,45).

Hyperlactacidemia causes acidosis and

also reduces the capacity of kidney to excrete uric acid, leading
to secondary hyperuricemia (46).

On the other hand, the enhanced

reducing equivalents can be transferred into the synthetic process
of fatty acids (47) and a-glycerophosphate (48), which are

9

precursors of triglycerides.

Reducing equivalents are also transferred

into the mitochondria by various shuttle mechanism, e.g., "grycerophosphate shuttle" (Figure 2) or "malate shuttle" (Figure 3) (49).
Presumably these are the major mechanisms for disposing of the
excessive reducing equivalents in the cytosol of liver (34).
Consequently, these excess reducing equivalents provide alternative
mitochondrial fuel originating from ethanol rather than from fatty
acid oxidation through the citric acid cycle.

Fatty acids usually

serve as a main source of energy in the liver; however, these are
supplanted by ethanol.

Decreased fatty acid oxidation by ethanol

has been evidenced in rat and human liver slices (50), perfused
livers (40), human liver (51) and in vivo (52).

Consequences of

these decreased oxidation of fatty acids are the accumulation of
dietary fat in the liver, when available, or accumulation of
endogenously synthesized fat in the liver when dietary fat is not
available (53-56).

The redox changes in liver caused by acute

administration of ethanol continues after chronic ethanol feeding
in rats (57).

Therefore, chronic ethanol consumption produces the

progrression of alcoholic liver injury beyond fatty liver (58).
Effects of Acetaldehyde
Oxidation of acetaldehyde proceeds via aldehyde dehydrogenase,
80% of which is located in mitochondria (59-60).

Oxidation of

acetaldehyde also generates NADH + H+, and as in the case of ethanol,
some of acetaldehyde effects may be attributed to the NADH generation.
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However, acetaldehyde is considered to exert its own toxic effect
due to its high chemical activity.

The mean acetaldehyde level

was shown to be significantly higher in alcoholics (42.7
than in nonalcoholic sub~ccts (26.5

~

~

1.2 µmole)

1.5 µmole) (37).

The reduced oxidation of acetaldehyde coupled with an enhanced
production from ethanol oxidation may cause the accumulation of
acetaldehyde in alcoholics.

Indeed Hasumura et al. (38) found that

the liver mitochondria subjected to alcohol had a significantly
reduced capacity to oxidize aldehyde (rate of disappearance :
11.8 + 0.8 vs 14.6

~

0.7 µmole/min; ethanol vs control).

Acetaldehyde

was found to reduce the activities of various mitochondrial shuttles
involved in the disposition of reducing equivalents and to inhibit
oxidative phosphorylation (61).

Acetaldehyde also depresses the

capacity of hepatic mitochondria to oxidize fatty acids (62) as
does the ethanol (63).

In some studies (64,65), addition of

acetaldehyde to liver slices was shown to inhibit protein synthesis.
As with ethanol, acetaldehyde generates an excess of reducing
equivalents and hence may increase the lactate/pyruvate ratio.
Induction of Microsomal Enzymes by Prolonged
Ethanol Intake
Various mechanisms including central nervous system adaptation and
increased activity of the MEOS have been postulated as means of increased
tolerance during prolonged alcohol consumption.

However, from the studies
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in animals (66,67) and humans (66,68), it has been observed that MEOS
plays a major role in the adaptive increase in ethanol metabolism after
chronic ethanol intake.
tions (26.Q

~

4.6 vs 8.9

Indeed, elevated cytochrome P-450 concentra~

2.1 pmole/mg microsomal protein) and

microsomal enzyme activities have been reported in the upper small
intestine after chronic ethanol consumption in rats (69).

The MEOS has

been defined as constituting of cytochrome P-450, NADPH, cytochromeC-reductase, and phospholipids, most of which are the component
of the microsomal drug metabolizing enzyme system (70).

Ethanol

ingestion has been found to cause a proliferation of the smooth
membranes of the hepatic endoplasmic reticulum (43), and hence,
both phospholipid and total protein content of the smooth membranes
were increased (71).

Functional implications for these changes

involve accelerated metabolism of drugs and other xenobiotics to
polar metabolites.

For instance, ethanol pretreatment remarkably

stimulates the toxicity of carbon tetrachloride (CCl4} in experimental
animals (72).

Also pretreatment of rats with phenobarbital, an

inducer of the hepatic microsomal drug-metabolizing system, increased
CCl4 toxicity in the liver (73).

Moreover, this induction of enzymes

of the endoplasmic reticulum may promote lipid peroxidation, leading
to another potential hepatic toxicity (71).
Effects on Drug Metabolism
Acutely intoxicated alcoholics are markedly susceptible
(increased sensitivity) to various drugs such as sedatives and
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hypnotics, whereas the chronic alcoholics are extremely resistant
to even large doses of similar drugs (1).

In the acute alcoholics,

the increased susceptibility may be partly due to combined effect
of ethanol and drugs on the central nervous system (1).

In addition

to that, recent studies (74,75) demonstrated that ethanol inhibited
the hepatic metabolism of a variety of drugs in vitro.

In other

studies (76,77), the simultaneous administration of ethanol and
drugs decreased the rate of drug metabolism in vitro.

It is thought

that ethanol per se, rather than its metabolities, interferes with
the binding of drug substrates of cytochrome P-450 and hence
decreases their detoxification (77,78).

On the other hand, in

chronically intoxicated individuals, drug metabolism is increased
because of proliferation of the smooth endoplasmic reticulum and
increased activity of some microsomal drug-detoxifying enzymes
(71,74,79).

In a recent study (80), it was observed that chronic

ethanol administration induced cytochrome P-450 with specific
spectral and catalytic properties diff~rent from those of cytochrome
P-450 of control animals and those treated with other drugs.
Therefore, in addition to nervous system adaptation, the induction
of microsomal drug-detoxifying enzymes may account for the resistance
of chronic alcoholics to the effects-of various drugs.
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4.

PATHOGENESIS OF ACUTE AND CHRONIC ETHANOL
ADMINISTRATION

Acute Effects of Ethanol on Liver Lipids
In one study (81), it was reported that a single large dose
of ethanol (4.2-6.2/kg body weight) given to rats by stomach tube
or intraperitoneal injection produced a significant accumulation
of triglycerides in liver within 12-16 hr.

However, this fatty

liver was markedly reduced when the ethanol administration was given
in divided doses during certain time intervals (82).

An acute dose

of ethanol stimulates both hypothalamus-pituitary-adrenocortical
(83) and sympatho-adrenomedullar (84) systems.

The release of

cathecholamines by ethanol is important because cathecholamines
promote free fatty acid release from adipose tissue and accumulation
of triglycerides in liver (85).

This acute fatty liver can be

prevented by the administration of S-adrenergic blocking agents,
hypophysectomy, adrenalectomy, and spinal cord transaction (86).
More importantly, ethanol per se alters lipid metabolism and is
associated with a variety of secondary effects.

These cause

change and damage in cell population in both gastrointestinal
tract (87) and peritoneum (88) resulting in systemic stress.
Effects of chronic ethanol administration is much more complicated.
Chronic Effects of Ethanol on Liver Lipids
In animal experiments in which ethanol had no lipotropic effect,
the alcohol was administered in drinking water at amounts equivalent to
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only 10-25% of the total calories in the diet (86).

However, when

the intake of ethanol by rats was increased up to 36% of the total
calories in liquid diets for rats, equivalent to moderate alcohol
consumption in man (12), the effects were found.

In this diet)

isocaloric replacement of some of the carbohydrate by ethanol
consistently produced 5-10 fold increas~s (89.4 ±_ 11.1 vs 11.3 ±_ 1.3
mg/g liver) in hepatic triglyceride concentrations in rats (12).
In humans with normal livers, fatty liver also developed when ethanol
was administered as a supplement to normal diets or as isocaloric
substitution for carbohydrate (12,88,89).

However, simple isocaloric

replacements of carbohydrate by fat or administration of carbohydrate
deficient diets in normal rats did not produce fatty liver as
ethanol did (12).

This finding indicates that in alcoholics,

fatty liver is due to ethanol and not to the manipulation of the
non-ethanol sources of calories (12).

The lipid accumulation was

apparent after a few days (19) or even after one day (90) of ethanol
administration.

The greatest increase .is associated with the

triglycerides content, although other lipid classes such as
phospholipids (12) and cholesterol (10) also accumulated in the
liver after chronic ethanol administration.

The increase in hepatic

cholesterol occurs mainly in the esterified fraction with little
elevation in free cholesterol (10).
Ethanol-Induced Fatty Liver
Fatty liver is characterized by an abnormal accumulation of
lipid consisting principally of triglycerides.

Fatty liver occurs
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when the rate of triglyceride formation exceeds its disposition
from the liver.

This formation of triglycerides depends on an

influx of fatty acids into the liver and/or the rate of synthesis
of fatty acids by the liver with subsequent e:sterification into triglycerides.

Removal of fat from liver is carried out by its

secretion as very low density lipoprotein particle (VLDL) into
general circulation or by the oxidation process (to CO2 and H20).
Catabolism of fatty acid is mainly carried out by S-oxidation.
Overall oxidation of fatty acids involves:
1.

activation of fatty acid to acyl-CoA in the cytoplasm;

2.

entry into mitochondria via carnitine acyltransferases;

3.

oxidation (S-oxidation consists of these three steps); and

4.

oxidation of acetyl CoA through the citric acid cycle
to CO2 and H20.

In the study by Blomstrand et al. (50), addition of ethanol
to rat and human liver slices depressed the formation (3.6% vs 8.2%)
of 14co2 from linoleic acid-1-14c.

In .this study, as a result of

ethanol addition, the esterification of triglycerides (45.6% vs
24.4%) and phospholipids (28.6% vs 19.8%) was increased, and the
formation of S-ketoacid was decreased (15.9% vs 43.9%).

A significant

depression of the 14co2 excretion from 14c-labelled oleic acid was
observed when it was administered orally or by intravenous injection
to humans as trial ein with ethanol (52).

These results suggest that

ethanol inhibits S-oxidation of fatty acids and increases esterification
of free fatty acids thus promotes accumulation of hepatic triglycerides
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and phospholipids.

In another study conducted by DeCarli and Lieber

(10), isocaloric replacement of carbohydrate by ethanol in rat diet
resulted in a significant increase of hepatic total lipids (96.8
6.6 mg/g vs 46.1

~

1.3 mg/g).

~

In a similar study, Lieber et al. (12)

also reported ethanol replacement of carbohydrate in the diet
caused a morphological change of the liver in man and increased
hepatic total lipids (129.4
(89.4
~

~

11.1 vs 11.3

~

~

9.2 vs 43.2

~

1.2 mg/g), triglycerides

1.3 mg/g), and phospholipids (31.4

~

1.1 vs 28.8

1.2 mg/g) in rats fed ethanol as 36% of total calories.

Ethanol-Induced Cirrhosis
After chronic administration of ethanol, the metabolism of
amino acids is depressed in the liver (91).

In animals fed ethanol

chronically, the concentrations of branched-chain amino acids (such
as leucine) increased in both liver
and plasma (235

~

16 vs 133

~

(273

~

32 vs 153 + 15 nmole/g)

17 nmole/ml) (92).

In liver slices

of ethanol-fed animals, the production of a-amino-n-butyric acid
(AANB) was increased 1-3 fold compared ·to control animals (93).
The hepatic damage caused by ethanol includes accumulation of fat
and the enlargement of hepatocytes and the diameters of hepatic cells
are increased 2-3 times with an increased volume of 4-10 fold.

This

morphological change is generally called alcoholic hepatomegaly.
The ballooning of hepatocytes coupled with necrosis causes alcoholic
hepatitis, and alcoholic hepatitis further develops to alcoholic
cirrhosis.

However, in some populations (Europe and Japan) alcoholic

cirrhosis develops without an intermediate stage of hepatitis (138).
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Cellular injury is also associated with extracellular deposition
of collagen.

In the fatty liver stage, collagen is detectable by

chemical means only (94).

When collagen deposition is sufficient

to become visible by microscope, it is called pericentral sclerosis.
This deposition of collagen in the perivenular area (pericentral
sclerosis) further develops into diffuse fibrosis and cirrhosis (95).
5.

MECHANISM OF THE ETHANOL-INDUCED ACCUMULATION OF
FAT IN THE LIVER

Role of Carbohydrate
Theoretically carbohydrate can contribute to the biosynthesis
of fatty acids in liver by supplying the carbon skeleton.

However,

the role of carbohydrate in ethanol-induced accumulation of fat
in liver has not been studied.

On the other hand, effects of ethanol

in carbohydrate metabolism is well established.

In a chronic alcoholic

case, increased availability of lactate may stimulate collagen production and

enhance hepatic collagen P.roline hydroxylase activity

which also play a role in collagen accumulation (96).

The altered

redox state may contribute to the hypoglycemia through impairment
of gluconeogenesis from amino acids (97).

Galactose oxidation in

the liver is also inhibited by alcohol via lowering urine diphosphate
glucose isomerase which is readily inhibited by NADH.
this effect is not clinically important (97).

However,
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Role of Protein and Amino Acid
In a study (98), the high dietary protein was found to have
no effect on the ethanol-induced hepatic triglyceride accumulation
(55.7

~

6.8 vs 52.3

~

4.9 mg/g : in 12.5% of total calories as

protein vs 25% of total calories as protein, respectively).

However,

protein contributes to the ballooning of the hepatocyte which is a
conspicuous feature of alcoholic fatty liver.

This hepatomegaly

is mainly attributed to fat accumulation, but fat accounts for only
half of the increase in liver dry weight and the other half is
accounted for by an increase in protein (99).

In this study,

Baraona et al. have reported that the liver retained proteins such
as albumin and transferrin.

In chronic liver injury, there is a

tendency for concentrations of the branched-chain amino acids, valine,
leucine and isoleucine to increase and for concentrations of tyrosine,
phenylalanine, glutamic acid, methionine, and sometimes, cystine to
fall in the liver (3).

Treatment with methionine, (30) has been

reported to reduce ethanol-induced hepatic accumulation of triglycerides
in the liver from 105.3

~

6.1 mg/g to 69.6

~

4.9 mg/g.

Role of Dietary Lipids
The degree of fatty liver caused by ethanol intake depends
on the amount of dietary fat.

Reduction of dietary fat to a level

of 25% or less of total calories in the diet significantly reduced
hepatic fat accumulation in rats fed ethanol (98).

In this

study, much more hepatic triglycerides (75 vs 17 mg/g) accumulated
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with a diet of high fat content (43% of total calories as fat)
than with a low-fat diet (10% of total calories as fat) wh~n an
identical amount (36% of total calories) of ethanol was administered.
In addition to the amount of fat in the diet, the chain length of
fatty acids is also important in the degree of fat accumulation.
Replacement of dietary fat containing triglycerides of long chain
fatty acids by triglycerides containing medium chain fatty acids
reduced the accumulation of total lipids (48.1 ±_ 4.2 vs 118.8

+

13.1

mg/g) and triglycerides (32 vs 77 mg/g) in the liver of ethanol-fed
rats (30).

Lieber et al. (54) found that fatty acid compositions

in liver fat are similar to those of dietary fat in the case of
prolonged ethanol ingestion but not with an acute dose.

In another

study of Lieber (53), the increase in hepatic total lipids in ethanolfed rats was 2.6 fold with the high fat diet (4.3% fat) compared
to control, but only 1.5 fold with the low fat diet (2% fat); the
corresponding changes in triglycerides were 6.3

and 2.6 fold,

respectively.
Dietary fat mainly consists of triglycerides containing long
chain fatty acids.

Triglycerides are hydrolyzed in the intestinal

lumen to monoglycerides and fatty acids prior to absorption.

In

the intestinal mucosa, triglycerides are resynthesized and released
into lymph as chylomicrons (as a packet of triglycerides, cholesterols,
phospholipids, and B-apolipoprotein).

Medium chain fatty acids are

absorbed and carried directly to the liver via portal blood.

However,

chylomicron triglycerides must be hydrolyzed to fatty acids before
entering the hepatocyte.
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Nondietary Lipids
Unlike chronic administration of ethanol, administration
of a single large dose of ethanol to rats resulted in hepatic fatty
acids accumulation similar to those of adipose tissue (100}.

Ir.

another study (53), it was demonstrated that after a single large
dose of ethanol (7.5 g/kg}, concentrat1ons of hepatic total lipids
were significantly increased (81.0

~

3.3 vs 46.8

~

1.4 mg/g}, and

fatty acid compositions of hepatic triglycerides and free fatty
acids were similar to those of adipose tissue.

Evidently, in these

cases (acute ethanol administration}, increased hepatic fat is
considered to be originated from increased peripheral fat mobilization.
Other than this enhanced mobilization of peripheral fat, possible
theoretical mechanisms of increased hepatic fat have been postulated
as:

(a) increased uptake of fatty acids by liver because of

stimulatory effects of ethanol on hepatic blood flow (101,102); (b)
increased biosynthesis of fatty acids in liver from normal carbohydrate
precursors (53,54) or from the carbon ~keleton of ethanol (103); (c)
increased esterification of fatty acids because of increased
availability of glycerides from increased dihydroxyacetone phosphate
and subsequent a-glycerophosphate (41,48,104); (d) increased synthesis
of cholesterol esters (105) (in ethanol-fed rats, enhanced incorporation
of labeled acetate into cholesterol was reported (105); (e) decreased
oxidation of fatty acids (50,52); (f) decreased hydrolysis of fatty
acid esters due to depressed activity of acid lipase and esterases
(106,107); (g) decreased excretion of hepatic fat into bile (major
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lipids excreted into bile are phospholipids and cholesterol) (108,109);
and (h) decreased release of lipoproteins (92).

Therefore, as a

summary, fatty liver may result from any combination of:

increased

influx of fatty acids into the liver; increased synthesis of fatty
acids in liver; decreased oxidation of hepatic fatty acids; and
impaired removal of hepatic fat.

However, a recent consensus has

developed that the most important mechanism responsible to ethanolinduced fatty liver ·is impaired oxidation of fatty acids (52,106).
6.

ETHANOL-INDUCED HYPERLIPEMIA

Alcoholic hyperlipemia is classified as Type IV (110) since
particulate fat behaves as VLDL on untracentrifugation and as preB-lipoproteins on electrophoresis.

In alcoholic hyperlipemia,

serum triglyceride is the main fraction which is elevated, but
serum phospholipids and cholesterol are also increased (86).

Very

low density lipoproteins are the major triglyceride-carrying lipoproteins from liver.

Ethanol enhanced the incorporation of

chylomicron fatty acids into newly synthesized VLDL, as evidenced
by an increased reappearance of the labelled fatty acids after
injection of palmitate-14c;glycerol-3H which was double-labeled (8).
This indicates that alcohol hyperlipemia is due partly to an
increase in newly synthesized lipoproteins (8).

In summary, hyper-

lipemia occurs when the entry of lipids into blood exceeds their
removal.
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Acute Effects of Ethanol on Serum Lipids
A high dose of ethanol (180g/6 hr) to chronic alcoholics
produced hypertriglyceridemia (257.1 ±_ 31.2 vs 112 ±_ 22.1 mg/dl)
(111).

These effects of etha~ol on serum triglycerides were enhanced

when ethanol administration was followed or accompanied by a fatcontaining diet (112,113).

However, unlike in humans, acute

administration of ethanol to rats did not produce consistent
hyperlipemia (125 ±_ 26 vs 116 ±_ 9 mg/dl) (114).
Chronic Effects of Ethanol on Serum Lipids
Administration of 200-3009 of ethanol per day (100-200 mg/dl
blood) to humans for two weeks produced a 4-fold increase in serum
triglycerides (480 mg% vs 140 mg%) and some increases in cholesterol
(330 mg% vs 270 mg%) and phospholipids (360 mg% vs 220 mg%) (89).
After two to three weeks of constant ethanol administration, these
~levated levels of triglycerides returned to normal (145 mg%),
despite continuation, or even an increase in ethanol intake.
However, when a high fat-containing diet was accompanied by the
administration of ethanol, alcoholic patients with fatty liver
compared to control subjects had higher levels of serum triglycerides
(108 mg/dl vs 24 mg/dl) for a longer period (6 hr vs 2 hr).
Mechanism of Ethanol-Induced Hyperlipemia
Serum triglycerides and serum fatty acids are produced in
the liver and intestine, whereas cholesterol is produced in many
tissues and transported to the liver for excretion as bile salts.
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For the transport of these lipids from the liver, liver produces
VLDL and high density lipoprotein (HDL).

Very low density lipo-

protein carries lipids from the liver to other tissues, and HDL
serves to transport extrahepatic cholesterol to the liver for
excretion (115).

Serum triglycerides are hydrolyzed extensively

in many organs in the body, and serum fatty acids are stored in
adipose tissue or oxidized in many tissues as triglycerides.
Accumulation of lipids in the blood occurs when the rate of entry
into the blood exceeds the rate of removal from the liver.

The

theoretical mechanism of ethanol-induced hyperlipemia is illustrated
in Figure 4 (86).
Interrelationship Between Serum and Liver Lipids
in Ethanol-Compromised Liver
Alcoholic hyperlipemia may play a compensatory role in counteracting lipid accumulation in the liver.

Indeed, full development

of ethanol-induced hyperlipemia after one month of ethanol administration (36% of total calories in the diet) to rats concurred with
the ceasing of the accumulation of lipids in the liver (98).

Although

disposal of hepatic lipids as serum lipoprotein into blood could
contribute to the alleviation of hepatic steatosis, this compensatory
effort is only partially effective and fatty liver is not prevented
by this mechanism.

When alcoholic fatty liver progresses to advanced

stages of liver injury, hyperlipemia decreases.

Such an inverse

relationship between the degree of alcoholic hyperlipemia and the
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FIGURE 4.

Theoretical mechanisms for ethanol-induced hyperlipidemia.
Ethanol intake could result in hyperlipidemia either
by enhancing the pathways illustrated with wide arrows
or by blocking those illustrated with broken lines (86).
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severity of liver damage have long been recognized (116).

Recently,

it has been observed that the decrease in VLDL, or pre-6-lipoprotein
could be an early indicator of the progression of fatty liver to
more severe hepatic lesions (117).
7.

PREVENTION OF ETHANOL-INDUCED FATTY LIVER

The fat accumulated in the liver with ethanol consumption
originates mainly from the diet and under restricted conditions,
from endogenous biosynthesis and so on.

In some studies, restriction

of dietary fat was reported to be effective in reducing accumulation
of liver fat in rats (98) and humans (54).

In addition to the

amount of fat in a diet, quality of the fat is also important in
causing the hepatic fat accumulation.

In rats, this accumulation

of hepatic fat was reported to be reduced by a substitution of mediumchain triglycerides for long-chain triglycerides (40).

This may

be due to the preferential oxidation of medium-chain fatty acids.
A variety of dietary and nondie~ary chemical agents have
been examined for the effectiveness in preventing fatty liver.
Many drugs, including clofibrate (20); asparagine, and barbiturate
(21) were found to be effective inhibiters of ethanol-induced fatty
liver in rats, but these drugs were usually tested against a single
large dose of ethanol.

Treatment with dietary choline protected

rats against ethanol-induced fatty liver but not humans (19).
Recently in rats (22), a remarkable protective effect against ethanolinduced fatty liver was exhibited by naturally occurring substances,
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riboflavin, dihydroxyacetone, and pyruvate.

In this study, results

showed that hepatic triglycerides were significantly reduced by
treatment with these chemical agents (see Table 1).

These agents

have a potential to accept hydrogen ions and correct the altered
redox state of the alcohol-compromised liver.

Earlier studies (118,

119) suggested that fortification of protein in the rat diet prevented
fatty liver, but more recent studies (98) have not supported this
finding.

Recently, Goheen et al. (120) reported a protective effect

of dietary arachidonate against alcoholic fatty liver.

In this

study, significantly reduced concentrations of hepatic triglycerides
(27.56

.:!:..

4.34 vs 68.4 + 6.37 mg/g) and phospholipids (19.4

.:!:_

2.4 vs

23.1 + 1.3 mg/g) were caused by treatment with arachidonate of ethanolfed rats.

TABLE 1.

Effects of Dietary Agents on Hepatic Fatty Acid Accumulation
by Ethanol (22)

Chemical Agent
-----------------------------mEq/100 g liver------------------------Ethanol
Riboflavin
Pyruvate + Dihydroxyacetone
Pyruvate + Dihydroxyacetone + Riboflavin
Pyrurate + Dihydroxyacetone +Riboflavin+ Thiamin

Note.

Values are mean+ SEM.

11.35
9.89
9.79
9.18

+
+
+
+

0.36
0.48
0.56
0.39

9.56 + 0.27

29
Effect of Carnitine
Carnitine, which has been recognized as vitamin Br (121),
is different from most other vitamins of its nature.

Carnitine can

be synthesized in the mammalian system (Figure 5) and is found in
large amounts in natural products such as meats (121).
In 1955, Fritz (27) observed that addition of carnitine to
a reaction mixture containing palmitic acid and a rat liver homogenate
caused an increase in the rate of oxidation of the fatty acids.
Furthermore, it has been found that synthetic palmitic carnitine
was oxidized much more rapidly by mitochondria than was palmitoyl-CoA
or palmitic acid (28).
Carnitine facilitates the transport of fatty acids via carnitine
acyl transferase into the mitochondria for B-oxidation (29).

Fatty

acids are normally oxidized in the mitochondria by B-oxidation,
i.e., removal of two carbon fragment at a time from the carboxyl
end of the fatty acid molecule.

This process depends on carnitine

acyltransferases within the mitochondrtal membranes which facilitate
the transfer of fatty acids into the site of 6-oxidation.

This

process is illustrated in Figure 6 (49).
Decreased fatty acid oxidation is incriminated as a major
causative mechanism for the accumulation of lipids in the liver.
Indeed, in recent studies, B-oxidation of fatty acids were reported
to be decreased in rat and human liver slices (50) when alcohol
was added (9.1 vs 4.2% of radioactivity recovered:

control vs

alcohol group with palmitic acid and 8.2 vs 3.6% of radioactivity
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Proposed pathway of carnitine biosynthesis (122).

31

Outside of
ruitochondrion

Inside of
mitochondrion

Mitochondrial membranes

----

[ Acetyl-CoAJ
r

CNE

CoA

t

CNE

CoA

I
I
I Fatty Acid
I Synthesis

I
I

I
I
I

.S-oxidation

I

,Fatty ac_yl-CoA

jFatty acyl
carnitine

.

Also derived from
exogenous sources
Note:

CNE = Carnitine
CCT = Carnitine acyl CoA
transferase

m

~o
lH-CH2
H2,I

" '~(CH3)3

c--o11

0

Carnitine Ester

FIGURE 6.

lhe role of carnitine in mediating acetyl and acyl transfers
across mitochondrial membranes (49).

32
recovered with linoleic acid) and in vivo in human liver (52) given
alcohol intravenousely (3.5 vs 6.4% of 14co2/given dose in ethanol
vs control in 5 hours).
Rudman et al. (23) demonstrated a carnitine deficiency in
alcoholic cirrhotic patients.

In this study, it was reported that

the cirrhotic group had significantly lower serum total carnitine
concentrations than a normal group (50% of normal concentration;
36

+

4 vs 79

+

3 µmole/dl) and also significantly lower serum

carnitine (free) concentrations (4.9
to a normal group.

~

3 vs 17

~

3 µmole/dl) compared

The beneficial effects of dietary D,L-carnitine in

ethanol-fed rats on fatty acid oxidation was reported by Hosein
and Bexton (24).

In this study, it was reported that D,L-carnitine

treatment (0.1 mg/g body weight) significantly lowered serum
triglycerides (111

~

5.2 vs 144

~

9.9 mg/dl) in rats which received

ethanol (6 g/kg body weight) by gastric intubation.

Hepatic

triglycerides were also reported to be significantly reduced by
carnitine administered at 0.5 mg/g body weight (75

~

3.4 vs 92

6.2 mg/g) in rats injected with ethanol (4 g/kg body weight).

+

This

argument is supported by evidence in Lieber's study (30) in which
the lipotropic effect of dietary carnitine (1 mg/cal) (114
vs 132.6

~

~

17.9

24.3 mg/g) on ethanol-induced fatty liver was demonstrated.

CHAPTER III
PROCEDURE
1.

EXPERIMENTAL DESIGN

Experiment 1
Thirty male Sprague-Dawley rats with an average body weight
of 207 g (189-218 g) were purchased from Harlan Sprague-Dawley, Inc.,
Indianapolis, Indiana and were divided into five groups of six animals
each (Table 2).

Animals were individually housed in 7' x 10' x 7
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wire mesh stainless steel cages and fed a nutritionally adequate
liquid diet (BioMix 711 from BioServ, Inc., New Jersey) containing
ethanol as 36% of the total calories (E), or a non-ethanol diet (NE)
in which ethanol was substituted isocalorically by maltose-dextrin
for 56 days (Table 3).
The ethanol diet was fed either as such or supplemented (W/W)
with 1.0% D,L-carnitine (EC); 0.5% L-lysine plus 0.2% L-methionine
(ELM); or a combination of the above levels of carnitine, lysine,
and methionine (ECLM).

The diets were prepared by mixing calculated

amounts of solid diet and chemical agents in cold water (4°C) every
other day in the morning, stored in the refrigerator, and fed at
4:00 P.M. in stoppered glass feeding tubes (Figure 7, BioServ, Inc.,
New Jersey).

The animals were allowed to adapt to ethanol diets

for three days, e.g., the ethanol was given in three increments (0%,
18%, and 36% of total calories during three days before feeding test
33
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TABLE 2.

Experimental Design for Experiment 1

Treatment
Number of Animals
Ethanol (%, V/V)
D, L-Carni tine ( %, W/W)
L-lysine (%, W/W)
L-methionine (%, W/W)

NE

E

6

6
6.4

Group
EC
6
6.4
1. 0

ECL

ECLM

6
6.4

6
6.4
1.0
0.5
0.2

0.5
0.2

Note. NE= non-ethanol, E = ethanol, EC= ethanol + carnitine,
ELM= ethanol +lysine+ methionine, and ECLM = ethanol + carnitine
+lysine+ methionine.

TABLE 3.

Bio-Mix #711 Isa-Cal Liquid Rat Diets (Lieber/OeCarli
Formula)

CONTROL

ETHANOL

-------------g/1---------------

PROTEIN
Casein (Vitamin free)
L-cystine
DL-Methionine

42.20
0.50

42.20
0.50

0.30

0.30

CARBOHYDRATE
Maltose-Dextrins

118.64

28.90

FAT
Corn oi 1
Olive oil
Ethyl linoleate

39.49
28.89
8.59
2.14

39.59
28.89
8. 59
2 .14

Ethanol

0.00

50.0

Vitamin Mix AIN- 76

2.01

2.01

Mi nera 1 Mix AIN-76

7.05

7.05
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FIGURE 7.

diets).

Liquid diet feeding tube.

All groups of animals were pair-fed with the unsupplemented

ethanol group (E).

The experimental design is shown in Table 2.

Experiment 2
Twenty-five male Sprague-Dawley rats born and reared in our
small animal facility with an average weight of 120 g (90-130 g),
were divided into five groups of five animals each (Table 2).
Animals were housed in facilities as described for experiment 1 and
were fed the liquid ethanol diets described for experiment 1 (Table
3} for 28 days.

The ethanol diet was given as such without

supplementation (Eo) or after being supplemented (W/W) with 0.2%
(E1), 0.6% (E2}, 1.0% (E3}, and 2.0% (E4) D,L-carnitine on a dry
weight basis.

Preparation and feeding of diets were carried out
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in the same manner as in experiment 1.

All groups of animals were

pair-fed with the unsupplemented ethanol-fed group (Ea).

The

experimental design is shown in Table 4.

TABLE 4.

Experimental Design for Experiment 2

Treatment

Eo

E1

Group
E2

E3

E4

Number of Animals

5

5

5

5

5

Ethanol (%, V/V)

6.4

6.4

6.4

6.4

6.4

D,L-carnitine (%, W/W)

0.0

0.2

0.6

1.0

2.0

Note.

E

=

Ethanol diet.

Experiment 3
For this experiment, male Sprague-Dawley rats were purchased
from Harlan Sprague Dawley, Indianapoli~, Indiana.

Thirty rats with

an average body weight of 213 g (196-224 g) were divided into six
groups of five animals each and were housed and fed in the same
manner as experiment 1 for 45 days.

The ethanol diet (Table 5) was

fed either as such without any supplementation (Eo), or after being
supplemented (W/W) with 0.1% (E1), 0.4% (E2), 0.8% (E3), 1.2% (E4),
and 1.6% (E5) D,L-carnitine on dry weight basis.
pair-fed with the E5 group.
Table 5.

All animals were

The experimental design is shown in
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TABLE 5.

Experimental Design for Experiment 3

Treatment

Eo

E1

Group
E2
E3

E4

E5

Number of Animals

5

5

5

5

5

5

Ethanol (%, V/V)

6.4

6.4

6.4

6.4

6.4

6.4

Levels of D,L-Carnitine
supplemented (%,W/W)

0.0

0.1

0.4

0.8

1.2

1.6

Note.

E

=

Ethanol diet.

2.

SAMPLE COLLECTION AND ANALYSIS

After the assigned feeding period with the test diets, animals
were sacrificed under sodium brevital (Eli Lilly and Co., Indianapolis,
Indiana) 16 hours after the last meal on the last day of the
The blood was collected in heparinized tubes

experimental period.

by heart puncture, and plasma was sepa~ated by centrifugation at
1500 xg and 4°C for 10 minutes in a refrigerated centrifuge.

Various

organs such as liver, heart, kidney, testes, skeletal muscle, and
brain were excised quickly, weighed, and frozen immediately in a
bottle of dry ice.

Plasma and tissues were stored in a freezer at

-60°C until analyzed.

Plasma was used for measuring the concentrations

of carnitine (123,124), proteins (125), total lipids (126), and
triglycerides (127).

Prior to analysis, the liver and other tissues

were thawed, kept on ice and minced thoroughly.

Representative
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aliquots of each tissue were used for determining the concentration
of DNA (128), total lipids (126), triglycerides (129), cholesterol
(130), phospholipids (131), free fatty acids (132), and carnitine
(123,124).
Total lipids in the liver in experiment 1 were determined
gravimetrically (137) and by the phospho-vanillin method (126).
Results of these two methods were compared.
3.

ASSAY PROCEDURE

Carnitines Determination
A.

Blood carnitine.

The concentrations of plasma carnitine

were determined by the radioenzymatic procedure of Cederblad and
Lindstedt (123) as modified in our own laboratory (124).

Total carnitine

content was calculated by adding the experimental values of free
carnitine, acid soluble acyl carnitine (ASAC, short chain acyl
carnitine), and acid insoluble acyl carnitine (AIAC, long chain acyl
carnitine) in each sample.

The determination is based on the

principle that carnitine is labeled from an enzymatic reaction with
labeled acetyl CoA as follows:
L-carnitine + (1-14c) acetyl CoA
+

~~.>

(1-14c) acetylcarnitine

CoA-SH

The reaction mixture was passed through an anion exchange resin
column which trapped out the unreacted acetyl CoA molecules, while
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allowing the labeled acetylcarnitine to pass through the column.
Thus, the eluate was collected, and the radioactivity was detected
in a liquid scintillation counter (Bekmann, LS lOOC. Beckmann
Instruments, Inc., Fullerton, California).
Reagents
1.

Carnitine standard solution (0.5 mM): 9.88 mg of L-carnitine-

HCl (Sigma Chemical Co., St. Louis, Missouri) was dissolved in cold
glass distilled water (GOW), and the total volume was brought to
100 ml with additional GOW in a volumetric flask.

One ml aliquots

of the solution were dispensed into plastic tubes and frozen at
-70°C.

Each aliquot was diluted appropriately for the working

standard solution.
2.

L-Palmitoyl carnitine standard (22.9 mM): 1.0 ml of GOW

was added to a vial containing 10 ml of L-Palmitoyl-carnitine (Sigma
Chemical Co., St. Louis, Missouri).

Thos solution was diluted

appropriately for the working standard solution.
3.

Phenol-red indicator (0.1%): 0.1 g of phenol-red was

dissolved in 100 ml of absolute ethanol.

Prereadied phenol-red tubes

were made by adding 1 drop of phenol-red to 12 x 75 mm test tubes
and allowed to dry.
4.

Radioactive acetyl CoA (50 mCi/mM): 50 uCi of (1-14c)

acetyl CoA (Amersham Corp., Chicago, Illinois) were dissolved in
300 ml of cold GOW.

Aliquots of 5.0 ml were dispensed into plastic

vials and frozen at -60°C.
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5.

Potassium bicarbonate (2M KHC03): 20 g of KHC03 was

dissolved in GOW and the total volume was brought up to 100 ml.
This reagent was stored in a refrigerator.
6.

Acetic anhydride (0.1 M (CH3C0)20): 0.5 ml of (CH3C0)20

was added to 4.95 ml of cold GOW, mixed, and used immediately for
the acetyl CoA solution preparation.
7.

Acetyl CoA (O.l mM): 10 mg of coenzyme A(P-L Biochemicals,

Milwaukee, Wisconsin) was dissolved in 0.5 ml of cold GOW.
solution, 100 µl of 1 M KHC03 was added.

To this

Then, 200 µl of 0.1 M

acetic anhydride was added and the volume was brought up to 80 ml
with GOW.

After mixing, the solution was dispensed into 5 ml volume

tubes and frozen at -60°C.
8.

Carnitine acetyltranferase (Pigeon Breast Muscle):

carnitine-)-acetyltransferase (Sigma Chemical Co., St. Louis,
Missouri) was diluted with GOW to 50 Units/ml.

This enzyme is

abbreviated as CAT in the procedure.
9.

MOPS (lM) (3-(4-morpholino) propanesulfonic acid)

(Eastman Kodak Chemical Co., Rochester, New York): 20.92 g of MOPS
was dissolved in approximately 80 ml of GOW.

The pH was adjusted

to 7.4 with 4N KOH, and the volume was brought up to 100 ml with
GOW.
10.

PCA/MOPS-1: 20.9 g of MOPS was added to 50 ml of 6%

perchloric acid (PCA), and the volume was made to 100 ml with GOW.
11.

PCA/MOPS-2: 20.9 g of MOPS was added to 20 ml of 6%

PCA, and the volume was made to 100 ml with GOW.
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12.

EGTA (0.1 M pH 7.0): 1.902 g of EGTA (Ethyleneglycol-

bis(beta-amino-ethylether)N,N'-tetraacetic acid) (Sigma Chemical
Co., St. Louis, Missouri) was dissolved in 30 ml of GOW and neutralized
with 4N KOH to PH 7.0.

The volume was made to 50 ml with GOW in

a volumetric flask.
13.

Radioactive acetyl CoA mixture (0.1 mM (1-14c)-acetyl

CoA solution): 2 volumes of (1-14c) acetyl CoA (#3) were mixed with
1 volume of cold 0.1 mM acetyl CoA (#6) and kept on ice.
14.

Reagent mixture (prepared fresh for each assay):

MOPS (IM) buffer

PH 7.4 (#8)

120 ~l

EGTA-K (O.lM)

PH 7.0 (#11)

20 µl
20 µl

Na2S405 (0.1 M)
Ratioactive acetyl CoA (0.1 mM)

200 µl

(#12)

40 µl

GOW
Sum
15.

400 wl

Bovine serum albumine (BSA) (8% Fraction V. F. A. poor

from ICN Nutritional Biochemicals, Cle~eland, Ohio): 4 g of BSA was
dissolved into 20 ml of GOW and stirred.

The volume was made to

50 ml with GOW in a volumetric flask.
16.

Scintillation fluid A: 33 g of PP0(2,5-0iphenyloxazole)

and 1 g of POPOP(l,4-Bis(2-(5-phenylexazolyl ))benzene) were dissolved
in 4 liter of toluene (C5H5CH3).
17.

Scintillation fluid B: 2 parts of scintillation fluid A

(#16) was mixed with 1 part of Triton X-100 (Fisher Scientific Co.,
Fair Lawn, New Jersey).
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Procedure.
Table 6.

Carnitine standards were prepared as shown in

For each sample, 50 µl of plasma was added to 200 µl of

6% PCA contained in a 12 x 75 mm test tube.

Since 400 µl was

desired for the final volume (to make identical volume as the
standard), 150 µl of GOW was added.

All test tubes were vortexed

and centrifuged in a refrigerated centrifuge (Model J-68, Beckman
Instruments, Palo Alto, California) for 10 minutes at 2900 xg at
0°C.

The PCA supernatant was analyzed for free carnitine and ASAC

as follows:
1.

Free carnitine determination:

150 µl of PCA supernatant

was transfered into a 12 x 75 mm phenol red test tube.
turned yellowish-orange in color.

The contents

Forty µl of 2M KHC03 was added

to the tube (golden yellow in color), vortexed, and then set on ice
uncovered for 30 minutes, after which it was centrifuged at 2900 xg
for 10 minutes.
2.

The supernatant was refrigerated until assay.

Acid soluble acylcarnitine determination:

100 µl

of PCA supernatant was transferred into a 12 x 75 mm phenol red
test tube (yellowish-orange in color), 60 µl of lN KOH was added,
and vortexed (purplish-red in color).

The tube was incubated for

30 minutes in a water bath for hydrolysis.
neutralized with 20 µl of PCA/MOPS-2.

The contents were

The mixture was vortexed,

precipitated by cooling on ice for 30 minutes, and then centrifuged.
The supernatant was refrigerated until assay was carried out.
3.

Acid-insoluble acylcarnitine determination:

The

remaining supernatant in the tube was drained off, and the pellet

TABLE 6.

Standard Mixtures of Carnitine

0.25 mM
Carnitine
{µl}
{nM}

0. 23 mM
L-Pa l mi tyl
Carnitine
{µl}
{nM}

Gowl
(µl )

8%
BSA2
(µl )

6%
PCA3
(µ l )

Total
(µl )

100

200

400

Total
Carnitine
(nM)

0

0

0

0

100

5

1. 25

5

1.15

90

2.40

10

2.50

10

2.30

80

4.80

15

3.75

15

3.45

70

7.20

20

5.00

20

4.60

60

9.60

0

lGlass distilled water.
2Bovine serum albumin.
3Perchloric acid.

...i:::,.

w
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was washed with additional 400 µl of 6% PCA.

The supernatant was

totally drained off with care until a dried pellet was obtained.
After adding 1 drop of phenol red indicator on the pellet, 100 µl
of 0.5N KOH was transferred into the tube.

The tube was vigorously

vortexed for several minutes until the pellet was completely dissolved
in KOH (purplish-red in color).

The tube was incubated at 65°C

in a shaking incubator (100 SPM) for 60 minutes for hydrolysis.
After hydrolysis, the contents were neutralized with 65 µl of
PCA/MOPS-1 (light-yellow in color).

The contents were vortexed

and precipitated by cooling on ice for 30 minutes.

The tube was

centrifuged at 2900 xg for 10 minutes at 0°C and refrigerated until
the assay was carried out.
4.

Carnitine assay:

the three fractions:

100 µl of supernatant from each of

free carnitine, ASAC, and AIAC, were

transferred into separate Eppendorf tubes.

Four hundred µl of

fresh reagent mixture was added to each tube, and 20 µl of enzyme,
carnitine acyltransferase were added. ·The mixture was mixed by
gentle tapping and then incubated at 37°C in a shaking water bath.
At the end of the incubation period, 200 µl of incubation mixture
was transferred on to a minicolumn (minicolumn was made by using
5-3/4" pasteur pipettes (Fisher Scientific Co., Fair Lawn, New Jersey)
with a small glass wool stuffing inside the pipette above the tip,
and anion exchange resin, AGI-X8, 200-400 mesh, Cl-form (Bio-Rad
Laboratories, Richmond, Acl) was added up to the 9 cm mark (measured
from the tip of the pipette).

After the mixture was absorbed into

45

the resin, the column was washed with 2 portion of 500 µl of GOW
into a scintillation vial (New England and Nuclear, Boston,
Massachusetts).

To each scintillation vial, 10 ml of scintillation

fluid B was added, and the vial was capped and mixed by swirling.
Radioactivity of the mixture was counted in a LS-lOOC Liquid
Scintillation Counter (Beckman Instruments, Irvine, California).
After the counts per minute (CPM) were recorded for all three
fractions(free carnitine, ASAC, and AIAC), the CPM of the blank
was subtracted from that of each standard fraction and from that
of each sample in that fraction (corrected CPM).

A standard

curve was plotted by using a regression line which was calculated
by a programmed least-squares method (Figure 8).

The contents of

carnitine for each of the three fractions was calculated as
fo 11 ows:

carnitine (nmole/ml)

=

corrected CPM .:':. b

----....,..M---) x D.F.

where:
b

=

Y-intercept in standard curve,

M

=

slope in standard curve,

D.F.

=

appropriate dilution factor.

Total carnitine content for each sample was calculated by adding
the values of free carnitine, true ASAC, and AIAC, in each sample.
The value of true ASAC was calculated as:
carnitine.

true ASAC

=

ASAC - free

This calculation was based on the principle that when

the ASAC fraction was hydrolyzed by KOH, both free carnitine and

~
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FIGURE 8.

Standard curves for carnitine (CNE, -o-), acid soluble acyl carnitine (A~AC, -o-),
and acid insoluble acyl carnitine (AIAC. -x-) obtained with carnitine and palmitoylcarnitine in a LS-lOOC Liquid Scintillation Counter.
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ASAC were liberated in that mixture.

Therefore, the equation for

the calculation of total carnitine is expressed as:

total carnitine =

free carnitine + true ASAC + AIAC.
B.

Tissue carnitine determination.

This procedure is

different from plasma carnitine determination only in the treatment
of tissue for carnitine extraction.

One hundred mg of tissue was

transferred into 1 ml of ice cold 3% PCA in a ground glass homogenizer
and homogenized while on ice.

The homogenate was transferred into

a small plastic vial and homogenizing vessel was rinsed with 2 portions
of 1 ml of 3% PCA into the vial (final volume= 3 ml).
were centrifuged at 4000 rpm for 10 minutes at 4°C.

The contents

Assigned aliquots

of supernatant were used for the determination of free carnitine
and ASAC fraction (150 µl for free carnitine and 100 µl for ASAC),
and the pellet was used for the determination of ASAC.

After this

step, the procedure was the same as for plasma carnitine determination.
Protein Determination
Total serum protein was determined by a conventional biuret
technique described by Gornall et al. (125).
Reagents.
1.

Biuret reagent:

90 grams of Rochelle salt (NaK tartarate-

4H20) (Sigma Chemical Co., St. Louis, Missouri) was dissolved in
about 400 ml of standard 0.2 N NaOH solution, and 10 gm of CuS04·
5H20 was added to it.

To the solution, 10 g of KI was added, and

the volume was made up to 2 liters with 0.2 N NaOH.
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2.

Standard serum albumin:

10 grams of crystalline bovine

serum albumin (ICN Pharmacenticals, Inc., Life Sciences Group,
Cleveland, Ohio) was dissolved in 100 ml of 0.9% saline.

A working

standard was made by diluting the stock solution to one tenth of
the original concentration.
Procedure.

The serum specimen (0.2 ml) was added to a test

tube (1.0 x 15 cm), and the volume was made up to 5.0 ml with GOW.
A reagent blank was prepared by adding GOW in place of the specimen.
A standard curve was plotted by using 5 volumes (0.1, 0.2, 0.4,
0.6, and 0.8 ml) of standard serum albumin in place of the specimen.
After the volumes were made up to 5.0 ml by adding GOW, all the
tubes were vortexed, and 5.0 ml of biuret reagent was added to all
tubes.

After standing for 30 minutes at room temperature, the

absorbance was measured at 540 nm against reagent blank.

The length

of light path of the spectrophotomeric cell used for these studies
was 1 cm.

A standard curve is shown in Figure 9.

Calculations.

The calculations are as follows:

Protein (mg/ml)

=

Au/As x Cs x O.F.

where:
Au

=

absorbance of unknown,

As

=

absorbance of standard,

Cs

=

concentration of standard,

O.F.

=

appropriate dilution factor.
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FIGURE 9.

Standard curve for serum protein obtained with bovine
serum albumin (BSA).
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Plasma Total Lipid Determination
Total lipid contents were measured by the phosphoric acidvanillin reaction method (126).

In this method, the lipid specimen

is heated with concentrated sulfuric acid; then vanillin and
phosphoric acid are added to yield a pink colored product.

The

chemical reactions that form the basis of this method remains
unknown (133).

One assumption that has been stated in several

published papers is that the unsaturated components of a lipid
specimen first oxidize to ketones and then under the influences
of acid catalysis the ketones condense with vanillin to a derivative
of vanillin.

Following this condensation reaction, dehydration

of an aldol-type intermediate is assumed to yield a more highly
unsaturated product that absorbs visible light.
Reagents.

Phosphoric acid-vanillin reagent was made by

dissolving 1.0 g of vanillin in 160 ml of distilled water in a 500 ml
volumetric flask.

Concentrated phosphoric acid was added to the

mark and mixed thoroughly.

A stock standard was made by mixing

1.0 g of olive oil in minimum volume of chloroform in a 100 ml
volumetric flask, and the mixture was diluted to the mark with
additional chloroform and mixed thoroughly.

This solution was

stoppered tightly and stored in a freezer (-20°C).

A working

standard was made by diluting the stock solution to one tenth of
the original concentration.

One ml of the stock solution was

transferred to a 10 ml volumetric flask, diluted to the mark with
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chloroform and mixed thoroughly.

The solution was stoppered tightly

and refrigerated.
Procedure.

Two hundred µl of serum was transferred to each

specimen tube and 200 µl of water to the blank tube; several assigned
amounts (50, 100 and 200 µl) of working standards were transferred
into some other tubes; the chloroform was evaporated off with a
stream of nitrogen; and then 200 µl of GOW was added to the standard
tubes.

Five ml of concentrated H2S04 was added to all the tubes,

mixed immediately and thoroughly with a vortex mixer.

The tubes

were stoppered tightly and heated at 100°C in a heating block for
10 minutes.

The tubes were allowed to cool to room temperature,

and then 200 µl of the contents of each tube were transferred to
small tubes (12 x 75 mm).

Phosphoric acid-vanillin reagents (3.0 ml)

was added to each tube- and mixed thoroughly with a vortex mixer.
All tubes were allowed to stand in a dark cabinet for 60 minutes.
Absorbances were read at 520 nm against a reagent blank in a
Beckman spectrophotometer (Model 34, Beckman Instruments, Fullerton,
California).

A standard curve is shown in Figure 10.

Calculations.

The calculations are as follows:

total lipids (mg/dl)

=

Au/As x Cs x 500

where:
Au

=

absorbance for the specimens,

As

=

absorbance for the standards,
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Standard curve for total lipid obtained with olive oil
at 520 nm.
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Cs

= concentrations of standard,

500

= appropriate dilution factor (200 µl x 500 = 100 ml).

Tissue Total Lipid Determination
Tissue (0.1 g) was transferred into a ground glass homogenizer
containing 1.0 ml of chloroform-methanol mixture (2:1, V/V) and
hand homogenized while keeping the hemogenizer in ice water.

The

homogenate was transferred into a small plastic vial, and the
homogenizing vessel was rinsed with two portions of 1.0 ml of
chloroform-methanol mixture (final volume= 3 ml).

The contents

were centrifuged at 2900 xg for 10 minutes at 4°C, and the supernatant refrigerated until analyzed.
Procedure.

Two hundred µl of homogenate supernatant was

transferred to each specimen tube and 200 µl of water to the blank
tube.

Several assigned amounts (50, 100, and 200 µl) of standard

were transferred to some other tubes.

The chloroform of both

specimen and standard tube were evaporated off with a steam of
nitrogen, and 200 µl of water was added.

The next step was carried

out in the same manner as for the determination of plasma total
lipids.
Plasma Triglycerides Determination
The contents of triglyceride in plasma were measured by the
method of Giegel et al. (127).

The procedure is based on the

principle that lipids are partitioned between water/isopropanol
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and noname phases with the triglycerides extracted into the nonane;
glycerol is liberated from the triglycerides by sodium hydroxide
and oxidized to formaldehyde by periodate; and the formaldehyde
reacts with 2,4-pentaned·ione to form 3,5-diacetyl-1,3-dihydrolutidine,
the colored compound.
Reagents.
1.

Extraction reagent: n-Nonane/isopropanol (2.0/3.5 by volume).

2.

Triolein standard: triolein* 100 mg/dl in extraction

reagent (1.13 mM/liter) *(Sigma Chemical Co., St. Louis, Missouri).
3. Dilute sulfric acid,. 40 mM/liter.
4.

Transesterifying reagent: NaOH in isopropanol (lOOmM/liter).

5.

Oxidizing reagent: sodium periodate, 18 mM/liter in

2.0 M/liter acetic acid.
6.

Color buffer: ammonium acetate (6.0 M/liter, PH 6.0 at

7.

Working color reagent: 4.0 ml of acetylacetone was added

25°).

to 100 ml of the color buffer; shaked vigorously; allowed to stand
for at least 15 minutes before use.

Fresh solution was made for

every batch of analysis.
Procedure.

The specimen (0.2 ml) was extracted with a

mixture of 5.0 ml of extraction reagent in a screw-capped test tube
(16 x 100 mm, #986), and 1.0 ml of dilute sulfuric acid was added
to the tube.

A reagent blank was prepared by adding water in

place of the specimen.

A standard curve was plotted by using three
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volumes (0.1, 0.2, and 0.4 ml) of standard in place of the volume
of extraction reagent.

All tubes were centrifuged at 100 rpm for

10 minutes to obtain a clear upper phase.

An aliquot (0.5 ml) of

each extraction upper phase was mixed with 0.5 ml of transesterifying
reagent and allowed to stand for five minutes at room temperature.
Oxidizing reagent (0.5 ml) was added to each tube, and the mixture
was allowed to stand for at least two minutes at room temperature.
A two-phase system was developed at this point.

Six ml of working

color reagent was added to each tube and mixed.

All tubes were

incubated at 60°C for 10 minutes for color development.

After

cooling to room temperature, the absorbance was measured at 415 nm
against the reagent blank.
Calculations.

The calculations are as follows:

triglycerides (mg/dl)

=

Au/As x Cs x D.F.

where:
Au

= absorbance of unknown,

As

= absorbance of standard,

Cs

= concentration of standard,

D.F.

= appropriate dilution factor.

Tissue Triglycerides Determination
Tissue triglycerides were measured by a spectrophotometric
method described by Sardesai and Manning (129).

This procedure

is based on the principle that involves extraction and saponification
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of triglycerides, the oxidation of glycerolmoiety to formaldehyde,
and the conversion of aldehyde to a color compount, i,5-diacetyl1-4-dihydrolutidine.
Reagents.
1.

Chloroform-methanol mixture:

two parts of chloroform

i n one ·part of met ha no 1 ( V/ V) .
2.

Silicic acid mixture: one part of silicic acid (Sigma

Chemical Co., St. Louis, Missouri) mixed with one part of Hyflo
Super-Cel (Sigma Chemical Co., St. Louis, Missouri).

The mixture

was activated by heating in an oven at 100°C overnight.
3.

Alcoholic potassium hydroxide: 2 g of KOH was dissolved

in minimum amount of water and diluted to 100 ml with 95% ethanol.
4.

Sulfuric acid, 0.2 N.

5.

Sodium arsenite, 0.05 N.

6.

Acetyl acetone reagent, PH 6.0 at 25°C: ammonium acetate

(150 g), 3 ml of glacial acetic acid, and 2 ml of acetyl acetone
were added in GOW and diluted to 1 liter (kept in a refrigerator).
7.

Triglycerides stock standard: one gram olive oil was

dissolved and diluted to 100 ml with chloroform and kept in a
refrigerator.
8.

Sodium metaperiodate, 0.05 N.

Procedure.

Procedure one was the calibration curve.

Working

standards ranging from 10 to 250 µg/ml (10, 50, 100, 150, 200, and
250) were made from the stock standard by dilution with chloroform.
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One ml of each of the standards was transferred into a 16 x 100 mm
test tube.

One ml of chloroform was pipetted into another test

tube (blank).

Chloroform was evaporated from the tubes in a boiling

water bath for 10 minutes; subsequently, 0.5 ml of alcoholic
potassium hydroxide was added, and all tubes were incubated 15
minutes in a 60°C water bath.

After incubation, 0.5 ml of 0.2 N

sulfuric acid was added to each tube followed by 0.1 ml of sodium
metaperiodate (to oxidize the glycerol released on saponification).
After exactly 10 minutes, the oxidation was stopped by adding 0.1 ml
of sodium arsenite.

After 5 minutes (to allow free iodine to

escape), 0.8 ml of GOW was added to each tube, followed by 2 ml
of acetyl acetone reagent, and mixed thoroughly.

The mixture was

incubated in a water bath at 58°C for 10 minutes, cooled to room
temperature and the optical densities were determined at 412 nm
against reagent blank.

Standard curve is shown in Figure 11.

Procedure two was with the tissue.

Preminced tissue (500 mg)

was accurately weighed and homogenized _with 2 ml of saline in a
ground glass homogenizer.

The homogenizing vessel was rinsed with an

additional two portions of saline (2 and 1 ml),
was made up to 5 ml.

and final volume

Ali quote of homogenate (0.5 ml) was

transferred into a 16 x 100 mm test tube, and 9.5 ml of extraction
solvent (chloroform-methanol mixture) was added.

The mixture was

filtered through nonlipid-containing filter paper (ether treated)
into a 60 ml separatory funnel containing 10 ml of GOW and shaken
vigorously.

After two layers separated, the lower layer was passed
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through a column (column was made by using 1 cm I.D. x 30 cm glass
column, 0.5 g of activated silicic acid mixture was packed into
the column, and wash with 5 ml of chloroform).

The eluate was

collected into a 10 ml volumetric flask and the column washed with
additional chloroform until eluate was up to the 10 ml mark.
aliquot

An

(3 ml) of eluate was transferred into a test tube (made

3 test tubes:

2 of them were duplicated for saponified samples

and the other one was for unsaponified sample).

All test tubes

were incubated in a heating block at 100°C for 10 minutes.
Subsequently, 0.5 ml of alcoholic potassium hydroxide was added
to the first two test tubes (saponified), and 0.5 ml of 95% ethanol
was added to the other test tube (unsaponified).

After this step,

the procedure was carried out as described for the preparation of
the calibration curve.

The absorbance of the saponified sample

minus that of the unsaponified represented the absorbance of the
triglycerides in the amount of the sample analyzed.
DNA Determination
Deoxyribonucleic acid contents in each sample were measured
by a modified method of Ceriotti (128).
Reagents.
1.

PCA, 0.6 N (Fisher Scientific Co., Fair Lawn, New Jersey):

25.7 ml of 70% PCA was diluted to 500 ml of GOW.
2.
with GOW.

PCA, 0.2 N:

17.2 ml of 70% PCA was diluted to 1 liter

60
3.

PCA, 1.2 N:

51.5 ml of 70% PCA was diluted to 500 ml

with GOW.
4.

KOH, 0.3 N (Fisher Scientific Co., Fair Lawn, New Jersey):

8.42 g of KOH was added to minimum amount of GOW and diluted to
500 ml.
5.

KOH, 0.1 N:

2.81 g of KOH was dissolved in minimum amount

of GOW and diluted to 500 ml.
6.

Indole, 0.04% with 60 µmole CuS04 (Fisher Scientific,

Pittsburgh, Pennsylvania):

40 mg of indole was added to a 100 ml

volumetric flask and 25 ml of GOW was followed.

The flask was

incubated in a boiling water bath for one hour.

At the end of

incubation, 0.06 ml of 0.1 M CuS04 was added, and the volume was
made up to 100 ml with GOW.
Procedure.

The solution was stored in a refrigerator.

A portion of liver (0.3 g) was homogenized with

2 ml of cold GOW in a ground glass homogenizer and rinsed with
an additional 2 ml of cold GOW two times (total volume was 6 ml).
An aliquot (5 ml) of homogenate was transferred into round bottom
tubes in duplicate.

To each tube, 2.5 ml of cold PCA was added

and mixed with vortex mixer (caution was taken to avoid precipitation
on the walls of tubes).
for 10 minutes.

The tubes were allowed to stand on ice

The mixture was centrifuged at 1500 xg for 15

minutes, and the supernatant was discarded.

The precipitate was

washed with 5 ml of cold 0.2 N PCA, mixed, and centrifuged for
12 minutes at 1500 xg for 12 minutes, and the supernatant was carefully
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discarded.

The washing was done twice.

The precipitate was dried

by inverting the tubes over filter paper.

To the tubes, 5 ml of

0.3 N KOH was added, and the tubes were capped and incubated at
50°C in a water bath (vortexed every 15 minutes).
transferred into a 50 ml volumetric flask.

The mixture was

To the flask, 12 ml

of 0.3 N KOH was added, and the volume was made to 50 ml with GOW.
A 2.0 ml aliquot of the extract was added to a test tube (1.0 x 15 cm),
and 1.0 ml of indole solution was subsequently added and mixed.
To the mixture, 1.0 ml of concentrated HCl was added, and it was
mixed again.

The tube was capped and incubated in a boiling water

bath for 10 minutes.

The mixture was cooled on ice for 10 minutes.

To the tube, 4.0 ml of chloroform was added, and the tube was capped
and shaken vigorously for 15 seconds.
at 1500 xg for 5 minutes.

The mixture was centrifuged

The pink layer at the bottom was

aspirated from the tube to another test tube (without losing yellow
colored DNA).

After repeating the steps from addition of chloroform

to aspiration, the tube was allowed to .stand at room temperature
for 30 minutes.

The yellow colored water phase was separated, and

the absorbance was measured at 490 nm against GOW as a blank.

A

standard curve was plotted by using 5 volumes (0.1, 0.2, 0.4, 0.6,
and 0.8 ml) of standard in place of sample.

A standard curve is

shown in Figure 12.
Calculations.

The calculations are as follows:

DNA (mg/g)

=

Au/As x Cs x D.F.
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where:
Au

=

absorbance for the unknown,

As

=

absorbance for the standards,

Cs

=

concentrations of standards

D.F.

=

appropriate dilution factor.

Cholesterols Determination
All classes of cholesterol of serum and tissue were measured
by the method of Searcy and Berquist (130).

This procedure is based

on the principle that an orange color is formed when cholesterol
and a solution of FeS04 in glacial acetic acid is treated with
H2S04; the colored product can be quantitated at a wave length of
490 nm.
Reagents.
1.

FeS04-acetic acid reagent:

a saturated solution was

prepared by adding several grams of FeS04·7 H20 to 1 liter of
reagent glacial acetic acid.

After a f.ew minutes of mixing, a

clear solution was obtained by filtration.
2.

Digitonin solution (5%):

in a 200 ml volumetric flask,

1.0 g of digitonin was dissolved in 100 ml of absolute ethanol at
60°C.

After addition of 2.0 ml of 10% acetic acid, the mixture

was diluted to volume with distilled water.
3.

Acetone/absolute ethanol:

4.

Cholesterol standard:

equal parts (V/V) were mixed.

a 60 mg/100 ml standard was

prepared by dissolving 120 mg of purified cholesterol in 200 ml

64
of acetone ethanol.

The solution was kept tightly stoppered in

a freezer and renewed frequently.
Procedure.

Total cholesterol, a 1 to 10 dilution was made

by adding 0.1 ml of specimen to 0.9 ml of acetone/ethanol.

The

mixture was stoppered, mixed well, and centrifuged at 1600 xg
for five minutes.

A 0.4 ml of aliquot of the clear supernatant

was placed in a test tube (10 x 150 mm) and diluted with 6.0 ml
of FeS04 reagent.

A 2.0 ml portion of H2S04 was added to the

mixture and mixed immediately using a vortex mixer to obtain
uniformity.

Ten minutes were allowed to elapse before colorimetric

measurement.

The absorbance were measured by a Beckman spectrophoto-

meter (Model 34, Beckman instruments, Fullerton, California) at
a wavelength of 490 nm against a reagent blank prepared with
0.4 ml of acetone/ethanol.

Calculations.

A standard curve is shown in Figure 13.

The calculations are as follows:

Total cholesterol (mg/dl)

=

·Au
As x Cs x D.F.

where:
Au

= absorbance of unknown,

As

= absorbance of standard,

Cs

= concentration of standard,

D.F.

= appropriate dilution factor.
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Free cholesterol.

A 1.0 ml aliquot of specimen was placed

in a conical centrifuge tube and mixed well with 1.0 ml of digitonin
solution.

After a 1 hour precipitation period, the mixture was

centrifuged at 1500 xg for lJ minutes.

The supernatant was discarded

and the precipitate was suspended in acetone-ether.

The mixture

was centrifuged again at 1600 xg for 10 minutes, and the supernatant
was carefully discarded.

The cholesterol precipitate was then

dissolved in 6.0 ml of the FeS04 reagent; the mixture was incubated
at 37°C for 5 minutes in a water bath to dissolve the
digitonide.

The solution was cooled to room temperature before

mixing thoroughly with 2.0 mi of H2S04.

The reaction mixture was

transferred to a spectrophotometric cell and the absorbance measured
in a Beckman spectrophotometer at 490 nm against a reagent blank.
Calculations.

The calculations are as follows:

Free cholesterol (mg/dl

=

Au/As x Cs x D.F.

where:
Au

absorbance of unknown,

As

absorbance of standard,

Cs

concentration of standard,

D.F.

appropriate dilution factor.

Esterified cholesterol contents were calculated by subtracting
the values of free cholesterol from those of total cholesterol in
each sample.

The equation is expressed as:

total cholesterol - free cholesterol.

esterified cholesterol

=

67

Phospholipid Determination.

The phospholipid content of

each sample was measured by a colorimetric method described by
Connerty et al. (131).

A trichloroacetric acid (TCA) filtrate of

plasma or ~~s5ue was treated with ammonium molybdate which reacts
with phosphate to form ammonium molybdophosphate.
to have the formula (NH4)3 [P04(Mo03)12].

This is thought

The addition of a suitable

reducing agent such as Elon (P-methyl aminophenol) produces a blue
color of heteropolymolyldenum blue.
Reagents.
1.

Digestion mixture:

a 50 ml of GOW was mixed with 25

ml of concentrated H2S04 and 25 ml of 70% perchloric acid.
2.

A 2.5% aqueous ammonium molybdate solution.

3.

Elon solution:

one gram of Elon (P-methyl aminophenol

sulfate) was dissolved in 100 ml of a 3% solution of sodium bisulfite.
4.

Trichloroacetic acid (TCA}, 5% W/V concentrations.

5.

Sodium acetate, 50% W/V solution.

6.

Phosphorus standard (1 mg/ml of P):

a 4.394 g of dried

potassium dihydrogen phosphate (KH2P04) was dissolved in sufficient

water to make 1 liter and acidified with 2 ml of concentrated H2S04
as a preservative before diluting to the mark.
7.

Working standard:

One ml of the phosphorus standard

was diluted to 250 ml with GOW (1 ml

=

4 µg of P).
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Procedure.

A specimen (0.2 ml) was transferred to a 16 x 150 mm

glass-stoppered 10 ml graduated tube.

Five ml of 5% TCA was added

drop by drop, mixing by lateral shaking, and then centrifuged at
1100 xg for 10 minutes until the precipitate was tightly packed.
The supernatant fluid was decanted and discarded and the tube was
inverted over filter paper until all the droplets of fluid adhering
to the wall of the tube was drained away.

One ml of digestion mixture

was added along with a small glass bead to the protein-phospholipid
precipitate and heated at 200°C for 15 minutes until a colorless
(or faint yellow) digest was obtained (one-half hour was sufficient).
The tubes were cooled for 2 minutes, 1 ml of GOW was added cautiously,
and heated to boiling for 15 seconds to convert any pyrophosphoric
acid into orthophosphoric acid.

One ml of 50% solution of sodium

acetate was added and GOW up to the 10 ml mark.

One ml of 2.5%

solution of ammonium molybdate was added and mixed with vortex mixer.
One ml of Elon reagent was added and thoroughly mixed again with
a vortex mixer.

The tubes were allowed to stand for 15 minutes

and the optical densities were measured at 700 nm against a reagent
blank.

The reagent blank was made by mixing 0.2 ml of concentrated

H2S04, 1 ml of 50% solution of sodium acetate, 1 ml of 2.5% solution
of ammonium molybdate, 1 ml of Elon reagent, and 8.75 ml of GOW.
A standard was prepared by mixing 20 µg of phosphorus (0.5 ml of
dilute standard) to the same mixture as the blank.
is shown in Figure 14.

Standard curve
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Calculation.

The standard contains 20 µg of phosphorus and

is compared with the phospholipid-phosphorus present in 0.2 ml of
serum.
Phospholipids (mg/dl)

=

Au/As x Cs x 25 x D.F.

where:
Au

=

absorbance of unknown,

As

=

absorbance of standard,

Cs

=

concentration of standard,

25

=

conversion factor for the fact that phosphorus
constitutes about 4% of average weight of
phospholipids.

D.F.

=

appropriate dilution factor.

-Free Fatty Acid Determination
The content of free fatty acid (FFA) of each sample was measured
by a colorimetric ultramicro method described by Novak (132).
method is based on the color reactions of copper soaps.

The

Cobalt

forms a ~oap with FFA that gives a color reaction with alpha-nitrosobata-naphthol (134).

The absorbance was read at 500 nm in the Beckman

spectrophotometer against the reagent blank.
Reagents.
1.

Solution A (Cobalt nitrate-acetic-potassium sulfate):

6.0 g of Co(N03)2-6H20 and 0.8 ml of glacial acetic acid were added
to a solution of K2S04 (saturated while boiling, stored in contact
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with excess crystals and filtered before use) go give a total volume
of 100 ml at 37°C.
2.

Solution B (saturated Na2S04 solution):

sodium sulfate

was added to boiling water until saturated, and kept at 37°C overnight.
3.

Cobalt reagent (triethanolamine, 1.35 volume).

was made up to 10 volumes with solution A.

this

Solution B (7 times

the volume of triethanolamine) was added to this and the mixture
was shaken.

The reagent is not stable so that fresh solution was

prepared for every batch of analysis.

Solutions A and B were kept

at 37°C.
4.

Indicator (stock solution, 0.4% alpha-nitro-beta-

naphththol in 96% ethanol):

this was diluted with ethanol by a

factor of 12.5 before use.
5.

Extraction mixture:

was prepared according to Dole (135)

in the procedure (isopropyl alcohol: heptane: lN H2S04

=

40:10:1,

V/V).
6.

Chloroform-heptane, 5:1 (V/V).

Procedure.

A 50 µl portion of sample was added to 250 µl

of Dole's extraction mixture in an Eppendorf tube.

The contents

were mixed with vortex mixer (care being taken not to allow them
to reach the stopper).

The tubes were cooled for 10 minutes in

a bath of melting ice.

A 300 µl volume of heptane was added;

500 µl of GOW followed; the contents were thoroughly mixed with a
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vortex mixer.

After two phases had separated, 300 µl was drawn

from the upper heptane phase and transferred to another Eppendorf
tube.

A 400 µl portion of chloroform-heptane was added, followed

by 500 µl of cobalt reagent, a~d the contents were thoroughly mixed
by vortexing for 3 minutes.

The mixture was centrifuged for 15

minutes at 1160 x g, and 600 µl of the upper chloroform/heptane
phase was transferred to another Eppendorf tube containing 750 µl
of indicator solution.

For the blank and standard, 50 µl of GOW

and standard respectively, instead of serum, were carried through
the operation.

Two standards (palmitic acid in Dole's extraction

mixture, 0.2 and 0.4 meq/liter) were prepared.

After 30 minutes

standing, absorbance was read at 500 nm in a Beckman spectrophotometer.

A standard curve is shown in Figure 15.
Calculations.

The calculations are as follows:

FFA (mg/dl) = Au/As x Cs x D.F.
where:
Au

= absorbance of unknown,

As

= absorbance of standard,

Cs

= concentration of standard,

D.F.

= appropriate dilution factor.
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4.

STATISTICS

All data were expressed as mean±_ SEM.* The data were analyzed
by using Analysis of Variance and Duncan's Multiple Range Test for
statistical significance at P<0.05 (136).

*SEM

=

standard error of mean.

CHAPTER IV
RESULTS
1.

EXPERIMENT I

The effects of carnitine and its precursors, namely lysine
and methionine, on ethanol-induced hepatic steatosis were examined
in three groups of healthy rats for an experimental period of 56
days and were compared with either an unsupplemented ethanol group
of rats or an unsupplemented nonethanol group of animals.
Unsupplemented ethanol-fed animals (E) consumed significantly
more food than non-ethanol (NE) animals or supplemented ethanol-fed
animals (Table 7).

Supplementation with carnitine and its precursors

significantly decreased daily food consumption, which was attributed
partly to poor intake during the first week of the feeding period.
The relative gain in body weight was NE>E>EC>ELM>ECLM (Table 6).
The weight gain for ELM and ECLM were significantly lower than for
the NE and E groups.

However, gains in body weight (g) per unit

volume (ml) of diet consumed were fairly consistent for all ethanolfed animals (E, EC, ELM, and ECLM:

2.1, 2,2 2,2, and 2.0,

respectively) but were lower than nonethanol-fed animals (NE, 2.5).
The weight of livers of the E group animals were significantly
heavier than those of the NE group of animals, as well as the
supplemented ethanol-fed groups (EC, ELM, and ECLM) (Table 6).
However, the weights of hearts, brains, kidneys, and testes showed no
significant differences among the group (Table 7).
75

TABLE 7.

Effects of Carnitine and its Precursors on Body Weight, Food Consumption, and Weight of Organs in
Ethanol-Fed Rats (Experiment I)

Gro~t

NE--

E

61.79+0.38a

64 . 64+ 1. 31 b

54.56+0.84C

53.67+0.94C

54.73+0.9QC

157.52+6.25a

136.50+12.05b

118. 90+8 .16bc

112.20+6.98C

107.70+5.14C

Liver (g)

11.22+0.14a

13.11+ 0.72b

10.95+0.31a

ll.18+0.40a

10.69+0.48a

Heart (g)

l.14+0.03a

1.12+ o.osa

1.10+0. 05a

l.10+0.03a

1.06+0.04a

Brain (g)

1.91+0.0Sa

1.87+ o.osa

l.86+0.04a

1.82+0.04a

l.83+0.04a

Kidney (g)

2.44+0.06a

2.37+ o.oaa

2.Jl+o.oga

2. 32+0 .11 a

2.30+0.o7a

Testes ( g)

3.67+0.10a

3.68+ 0.02a

3.73+0.13a

3.37+0.13a

· 3. 78+0. 10a

Food consumption (ml/day)
Weight gain (g)

ELM

-----------

ECLM

Note. The values are mean+ SEM for six animals. Values without a common superscript letter are
significantly different from each other (P<0.05). NE= non-ethanol, E = ethanol, EC= ethanol + carnitine,
ELM= ethanol +lysine+ methionine, and ECLM = ethanol + carnitine +lysine+ methionine.

-.J
0)
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Plasma concentrations (mg/g) of total carnitine contents
were significantly lower in the E and ELM group compared with the
NE group (Table 8 and Figure 16).

However, all supplemented ethanol-

fed animals (EC, ELM, and ECLM) showed significantlv elevated levels
of total carnitine when compared with the E group.

A markedly

elevated concentration of plasma total carnitine was found in the
EC group which is higher than even that of the ECLM group (Table 8
and Figure 16).

The highest plasma concentrations (mg/dl) of

triglyceride were found in the E group, followed by similar levels
in the ELM group.

The plasma concentrations of triglyceride were

lowest in the animals of the EC group but were not statistically
significant from those of the NE and ECLM groups (Table 8 and
Figure 16).

The concentrations (mg/g) of plasma protein were not

different among the groups (Table 8).
Hepatic DNA contents (mg/g) were not altered by treatment,
whereas all hepatic lipid classes were significantly affected by
supplemented agents (Table 9).

The con_centrations of total lipid,

triglyceride, esterified cholesterol, free cholesterol, total
cholesterol, and phospholipid were significantly increased in the
livers of the E group compared with the NE group and were significantly
reduced (except for phospholipid in the ELM and ECLM groups) from
those in the E group by treatment with supplemented agents (EC,
ELM, and ECLM groups (Table 9).

The values of both total lipid

and triglyceride were lowest in the livers of the EC group among
the supplemented groups (Table 9 and Figure 17).

On the other hand,

TABLE 8.

Effects of Carnitine and its Precursors on Plasma Concentrations of Carnitine, Triglyceride, and
Protein (Experiment I)

Grau
EC

Plasma Comeonent

NE

E

Total carnitine
(nmoles/ml)

249.98+11.63C

120.33+8.73a

334.90+25.sod

ELM

ECLM

169.23+7.S7b

238.ql+lo.ooc

Triglycerides (mg/dl)

29.83+ 3_45ab

49.64+9.92C

22.90+ o.ssa

43.72+4.92bc

30.20+ 3.osab

Protein (mg/ml)

67.83+ 3.20a

72. 07+2 .17a

65. 73+ 2. 18a

78.75+7.22a

72.80+ 4.saa

Note. The values are mean+ SEM for six animals. Values without a common superscript letter are
significantly different from each other (P<0.05). NE= non-ethanol, E = ethanol, EC= ethanol + carnitine,
ELM= ethanol +lysine+ methionine, and ECLM = ethanol + carnitine +lysine+ methionine.
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Effects of carnitine and its precursors on plasma
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and total carnitine ( ~ ) in ethanol-fed rats.

TABLE 9.

Effect of Carnitine and its Precursors on Hepatic DNA and Lipids in Ethanol-Fed Rats {Experiment I)

Parameters

NE

E

Groues
EC

--ELW

--- --- -E:cLM

---------------------------- {mg/g wet weight of liver) ------------------------------3.30+0.16a

2.97+ 0.10a

3.10+0.07a

3.07+0.01a

3.0l+o.14a

Total lipids

48.59+3.8oa

78.05+ 9.sob

55.95+4.Joa

59.52+3.8oa

56.82+3.ooa

Triglycerides

19.39+6.o5a

61.81+11.46b

23.42+6.02a

33.62+3.59a

33.02+8.68a

Esterified cholesterol

5. 72+0. 71a

8.56+ o.sab

6.13+0. 51 a

6.52+0.5oa

5.93+0.49a

Free cholesterol

1.11+0. osa

1.35+ 0.01b

l.16+0.39a

1.20+0. 02a

l.16+0.04a

Total cholesterol

6.84+1. 78a

9.92+ 1.57b

7 .30+1.23a

7.72+1.233

7.10+1.24a

Phospholipids

5.78+o.soa

a.02+ 0_59b

6.42+0.40a

6.94+0.Jaab

7.85+0.36b

Free fatty acids

9.91+0.84a

12.01+ 1.79ab

13.12+1.24bc

DNA

15. 86+1.81 C

14.91+1.06bc

Note. The values are mean+ SEM for six ~nimals. Values without a common superscript letter are
significantly different from each other {P<0.05). NE= non-ethanol, E =ethanol, EC= ethanol + carnitine,
ELM= ethanol+ lysine+ methionine, ECLM = ethanol + carniti~e +lysine+ methionine.
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Effects of carnitine and its precursors on plasma
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and triglyceride ( ~-) in ethanol-fed rats.
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the concentrations of free fatty acid were significantly increased
in all ethanol-fed animals compared with the NE group (Table 9).
Furthermore, of the supplemented ethanol-fed groups, significantly
higher concentrations of free fatty acid were found in the ELM group
compared with the NE and E groups (Table 9).
Although the gravimetric method (137) that was initially
used in the present study produced values more consistent with that
reported by Lieber and DeCarli (30) who also used gravimetric procedure
for total lipid determination in their studies, the spectrophotometric
(phosphoric acid-vanillin) method (126) yielded results in close
agreement with those by summing of the total lipid components of
a sample (Table 10 and Figure 18).

Therefore, the values of total

lipid content presented in this ~tudy are those determined by the
spectrophotometric phosphoric acid-vanillin method.
The concentrations (nmole/g) of hepatic carnitine (free
carnitine)were significantly elevated in the supplemented ethanolfed groups (EC, ELM, and ECLM) compare~ with unsupplemented nonalcoholic animals (NE) (Table 11 and Figure 19).

Among the

supplemented groups, only the EC group had significantly higher
concentrations of carnitine than those of the E group (Table 11).
The concentrations of carnitine in the E group were also elevated
compared to the NE group, but the difference was statistically not
significant (Table 11).

However, the concentrations of ASAC did

not differ among groups (Table 11).

The concentrations of AIAC

were significantly elevated in the supplemented groups:

EC, ELM,

TABLE 10.

Comparison of Analysis Methods for Total Hepatic Lipids (Experiment I)

Grau
Sources

NE

E

EC

ELM

ECLM

----------------------------(mg/g)--------------------------------------Gravimetric method

33.7+ 3.3

139.2+
-- 4.2

82.9+ 7.1

91.4+3.6

89.6+13.0

Spectrophotometric
method
(phosphovanillin)

48.6+- 3.8

78.1+ 9.5

56.0+ 4.3

59.5+3.8

56.8+ 3.0

Summationa

41. 9+14. 5

50.3+ 8.2

50.3+ 8.2

64.1+5.7

62. 9+10.6
--

Li tera tureb

58.0+ 2.5

132.6+24.3

114.5+17.9

asummation =triglyceride+ phospholipid + total cholesterol + free fatty acids.
bliterature values are cited from values reported by Lieber, C. S. and DeCarli, L. M.
(30) where gravimetric method was used for total lipids determination. Values are mean+ SEM.
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TABLE 11.

Parameters

Concentrations of Hepatic Carnitines in Rats Fed With and Without Carnitine and
its Precursors (Experiment I)

NE

Groups
EC

E

ELM

ECLM

(nmoles/g wet weight of liver)
Carnitine

365.2+23.4a
-

486.4+26.6ab
-

705.2+63.BC

-

533.8+26.ob

-

639.7+41.obc
-

ASAC

121. 2+25. 4a

209.0+57.la

218.2+27.4a
-

143.2+28.2a
-

213.0+23.4a

AIAC

5.7+- 0.3a

8.5+ a.gab

11. 5+ o .ab

10.8+ 0.5b

11. 4+ 1. ob

Total
carnitine

492.1+26.2a
-

703.9+58.3ab

-

934.8+85.5C
-

687.8+15.9ab
-

864. 0+51. 2bc

ASAC + AIAC
carnitine

0.35

0.45

0.33

-

-

0.29

0.35

Note. The values are mean+ SEM for six animals. Values without a common superscript
letter are significantly different-from each other (P<0.05). ASAC = acid soluble acyl carnitine;
AIAC = acid insoluble acyl carnitine; NE= non-ethanol, E = ethanol, EC= ethanol + carnitine,
ELM= ethanol+ lysine+ methionine, ECLM =ethanol+ carnitine +lysine+ methionine.
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and ECLM, compared to the NE group and also elevated in the E group
compared with the NE group but the latter difference was not
significant (Table 11).

The concentrations of total carnitine were

significantly elevated in the EC and ECLM groups when compared to
NE group (Table 11).

When compared with the NE group, the

unsupplemented alcoholic group (E) showed elevated concentration
of all species of carnitine but the differences were not significant
(Table 11).

The ratios of acylcarnitine (ASAC + AIAC) to carnitine

in the supplemented groups (EC, ELM, and ECLM) were much closer
to those in the NE group than those in the E group (Table II).
As shown in Table 12, the concentrations of total lipid in
organs such as skeletal muscle, brain, testes, and heart were not
statistically different among groups.

However, the concentrations

of lipids in kidney were significantly higher in both unsupplemented
alcoholic group (E) and supplemented alcoholic groups (EC, ELM,
and ECLM) when compared to NE group (Table- 12).

There appeared

to be a trend that the elevated concentrations of total lipid in
the kidney of ethanol-fed animals were decreased in the
supplemented groups (EC, ELM, and ECLM).

The concentrations

of triglycerides in the organs showed similar pattern of
changes as those of total lipid (Table 13).

All the organs except

kidney had no significant difference in the concentrations of
triglycerides among groups (Table 13). The kidney had significantly
elevated concentrations of triglycerides in the E group compared
to the NE group and reduced concentrations in supplemented groups

TABLE 12.

Organs

Effects of Carnitine and its Precursors on the Concentrations of Total Lipid in
Organs Other Than Liver (Experiment I)

NE

E

Grou
EC

ELM

ECLM

------------------------------(mg/g of wet weight)------------------------------~-Kidney

14. 20+0.
72a
-

20.14+2.53b

18. 22+1. 91b

18. 70+0. 72b

18.14+1. 91b

Skeletal
muscle

16. 31+1.
ooa
-

18.52+4.2oa
-

15.43+5.6la
-

17.32+5.2oa
-

15.35+3.15a
-

Brain

38.01+7.26a
-

33.58+4.56a
-

35.03+3.2oa
-

34.95+4.63a
-

34 . 14+4
- . 11 a

Testes

9.69+0.81a

11.16+
- 1. 52a

10. 72+1.
52a
-

11.34+0.75a
-

11.13+0.62a
-

Heart

17.81+1.71a

20·. 93+3. 68a

16.49+3.lBa

17.18+3.89a

19. 52+1. 23a

Note. The values are mean+ SEM for six animals. Values without a common superscript
letter are significantly different-from each other (P<0.05). NE= non-ethanol; E = ethanol;
EC= ethanol + carnitine; ELM= ethanol +lysine+ methionine, and ECLM = ethanol + carnitine
+lysine+ methionine.

CX)
CX)

TABLE 13.

Effects of Carnitine and its Precursors on the Concentrations of Triglyceride in
Organs Other Than Liver (Experiment I)

Grou
Organs

NE

E

EC

ELM

ECLM

-------------------------(mg/g of wet weight)-------------------------------------6. 98+1.
52a
-

10.85+2.13b

7. 62+ 1. 25ab

6.60+0.82a
-

7.00+l.88ab

Skeletal

10.19+1.45a
-

11. 48+1.
45a
-

8. 92+1.
02a
-

6. 60+1.
o8a
-

8.18+1. 07a

Brain

14.35+2.04a
-

11 . 78+2.
- 98a

11. 49+2.
- 89a

11.14+3.17a
-

11. 40+2. 53a

Testes

3.59+0.15a
-

4.07+0.47a
-

3.88+o.na
-

4.09+0.53a
-

4.o4+o.67a

Heart

10.39+0.66b

11. 49+o. 82b

7. 05+1. 25a

10 .10+1. 78b

9. 95+1. 33b

Kidney

-

Note. The values are mean+ SEM for six animals. Values without a common superscript
letter are significantly different-from each other (P<0.05). NE= non-ethanol; E =ethanol;
EC= ethanol + carnitine; ELM= ethanol +lysine+ methionine, and ECLM = ethanol + carnitine
+ lysine + methio.nine.
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(EC, ELM, and ECLM) compared with the elevated concentrations in
the E group with the lowest concentrations being in the ELM group
(Table 13).
2.

EXPERIMENT II

This study was designed to determine whether the lipidlowering effect of dietary carnitine on ethanol-induced fatty liver
was dose-dependent or not.

To determine the most effective

lipotropic dosage of dietary carnitine, various levels of D,Lcarnitine were supplemented in the nutritionally adequate liquid
ethanol diet used in Experiment I (Eo: 0.0%, E1: 0.2%, E2: 0.6%,
E3: 1.0%, and E4: 2.0% carnitine) (Table 4, page 36).

There appeared

to be no significant difference among all groups in the daily diet
consumption (Table 14).

Similarly, liver weights were not

significantly different among groups (Table 14).
in body weight (g) was as follows:

The relative gain

E1>Eo>E2>E4>E3 (Table 14).

However, the gain in body weight (g) p~r unit volume (ml) of diet
consumed showed a trend that the higher supplementation of carnitine
was associated with less gain in body weight (Ea: 1.16, E1: 1.33,
E2: 0.87, E3: 0.45, and E4: 0.48, respectively) (Table 14).

The

concentrations of plasma total carnitine (nmole/ml) were significantly
elevated in all the carnitine supplemented groups (E1, E2, E3, ~)
when compared to unsupplemented ethanol-fed animals (Eo), but did
not differ statistically among supplemented groups (Table 15 and
Figure 20).

Plasma levels of triglyceride were not affected

TABLE 14.

Effects of Various Levels of Carnitine on Food Consumption, Liver Weight, and
Body Weight Gain (Experiment II)

Parameters
Food intake
(mg/day, rat)
Liver (g)
Body weight gain
(g)

Groues
E2

E3

E4

29.06+1.88a
-

26.9 -+2.o6a

27.5 +2.15a

5.38+0.28a
-

5.46+0.29a
-

4.73+0.33a

4.75+0.02a

38.6 +l.39C

24.8 +3.19b

12.2 +3.17a

12.8 +2.68a

Ea

E1

32.2 -+l.61a

29.5 -+2.32a

5.40+0.35a
36.9+3.56bC
-

Note. The values are mean+ SEM for five animals. Values without a common superscript
letter are significantly differen~-from each other (P<0.05). E =ethanol.

~
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TABLE 15.

Effects of Various Levels of Carnitine on the Plasma Concentrations of Total Carnitine
and Triglyceride (Experiment II)

Eo

E1

Total carnitine
(nmole/ml)

30.54+2.36a

91.03+4.79b

Triglycerides
(mg/dl)

30.16+1.37b

29.19+1.64b

Groues
E2

E3

E4

105.10+1.83b

98.22+2.25b

106.93+2.62b

27. 90+1. 5gb

26.29+0.94ab

22.58+1.59a

Note. The values are mean+ SEM for five animals. Values without a common superscript
letter are significantly different-from each other (P<0.05). E =ethanol.
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significantly by treatment with carnitine supplementation up to
the 0.6% level (t1 and E2), but were slightly depressed by 1.0%
carnitine supplementation (E3) compared to the Ea group (Table 15
and Figure 20).
With 2.0% carnitine supplementation (E4), the levels of
plasma triglyceride were significantly lower compared to the unsupplemented group (Ea) (Table 15).

These changes can be expressed

as a 3.2%, 7.5%, 12.8%, and 25.1% decrease in the E1, E2, E3, and E4
groups, respectively, compared to the Ea group.

None of the hepatic

lipid parameters showed any significant changes in the carnitinesupplemented groups (Table 16).

However, the concentrations of

hepatic total lipid tended to be depressed by carnitine supplementation (Table 16 and Figure 21) compared to the unsupplemented group
(Ea), the levels of total lipid were decreased as much as 2.7%,
7.6%, and 9.2% in the E1, E2, and E3 groups, respectively, but
increased 0.74% in the E4 group.

The levels of hepatic triglyceride

showed a similar pattern as total lipids (Table 16 and Figure 21).
The percent change in hepatic triglecerides were 1.7%, 6.1%, 11.5%,
and 6.2% decrease in the E1, E2, E3, and E4 groups respectively,
when compared to the unsupplemented group (Ea).

Free cholesterol

decreased by 5.4%, 14.1%, 0.6%, and 29.5% in the E1, E2, E3, and
E4 groups, respectively.

On the other hand, esterified cholesterol

increased by 7.3%, 26.2%, and 15.0% in the E1, E2, and E3 groups,
respectively, but there was a 12.9% decrease in the E4 group
compared to the Ea group.

Thus, total cholesterol increased by

TABLE 16.

Effects of Various Levels of Carnitine on Hepatic Concentrations of Lipids (Experiment
I I)

Parameters

Eo

E1

Grou
E2

E3

E4

-----------------------(mg/g wet weight of liver)---------------------------To ta 1 1 i pi ds

48.80+5.853
-

47.46+2.41a
-

45.07+3.27a

44.32+2.583

49.16+6.983

Triglycerides

16.74+1.99a
-

16.09+0.843
-

15. 72+1. o6a

14. 82+0. 64a.

15. 71+1. 59a

Free cho 1es tero 1

1. 49+0.
- 09a

1. 41+0.
09a
-

1. 28+0 . 103

1. 48+0. 21 a

l.05+0.06a

Esterifi ed
cho 1es tero 1

2.33+0.323

2.50+0.583
-

2.94+0.163
-

2.68+0.15a
-

2.03+0.323
-

Total cholesterol

3.29+0.51a
-

3.55+0.573

4.22+0.22a

3.94+0.23a

3.10+0.25a

Phospholipids

3
4.55+0.27
-

4.88+0.263
-

4.45+0.43a

4 .85+0.173

4.77+0.28a

Free fatty acids

4.22+0.18a

4.28+0.25a

5.02+0.12a

5.52+0.15a

5.32+0.19a

Note. The values are mean+ SEM for five animals. Values without a common superscript
letter are significantly different-from each other (P<0.05). E =ethanol.
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7.9%, 28.3%, and 19.8% in the E1, E2, and E3 groups, respectively,
but there was a 5.8% decrease in the E4 group.

Changes in phospho-

lipid concentrations did not show any consistent pattern.

There

was a 7.2%, 6.6%, and 4.8% inrrease in the E1, E3, and E4 groups
respectively, but a 2.2% decrease in E1 compared to the Ea group.
However, when compared to the Ea group, there appeared to be
consistent increases in hepatic free fatty acid concentrations in
the supplemented groups (1.4%, 19%, 3a.8%, and 26.1% increase in
the E1, E2, E3, and E4 group, respectively) (Table 16).
3.

EXPERIMENT III

This study was carried out to further substantiate the doseresponse effect of carnitine-supplementation, as demonstrated in
Experiment II.

This was especially important in Experiment II in

which the animals were too young, and received the ethanol test
diet for only 28 days.

The levels of carnitine supplementation

tested were changed (see Experimental qesign).
In this experiment, the study was expanded in population
of animals (from 25 to 30) and in experimental period (from 28 to
45 days).

As shown in Table 17, only the E5 group showed a

significantly higher diet consumption than the other groups.
However, there was no significant difference among groups in
either body weight gain or weights of organs e.g., liver, kidney,
heart, and small intestine (Table 17).

TABLE 17.

Effects of Various Levels of Carnitine on Food Consumption, Body Weight Gain, and Weights of Organs
in Ethanol-Fed Rats (Experiment III)

Grau
Parameters

E3

- - --E4

Ea

E1

E2

Food intake
(ml/day, rat)

56.9I+0.85a

56.67+1.48a

57.I7+1.32a

55.31+ 2.s2a

54.89+1.32a

64.78+2.96b

Body weight
gain (g)

71.6 +1.oga

68.0 +5.37a

66.6 +5.37a

56.1 +10.03a

59.4 +5.63a

62.4 +9.84a

Liver (g)

10.97+0.s3a

10.27+0.36a

9.45+0.38a

8.83+ 0.79a

8.6l+0.2oa

10.45+0.97a

Kidney (g)

2 .14+0 .19a

1.9I+0.06a

2.08+0.24a

2.44+ 0.37a

2.27+0.27a

2 .18+0. 20a

Heart ( g)

1.22+0.21a

l.l8+0.22a

1.15+0.22a

1.55+ 0.29a

l.37+0.21a

1. 24+0. 21 a

Small
intestine (g)

5.53+0.27a

6.12+0.13a

6.67+0.59a

5.69+ 0.37a

6.17+0.38a

6.07+0.58a

E5

Note. The values are mean+ SEM for five animals. Values without a common superscript letter are
significantly different from each other (P<0.05). E =ethanol.
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Plasma concentrations (mg/g) of total lipids were significantly
reduced by carnitine treatment with the lowest contents being found
in the E3 group (Table 18 and Figure 22).

Higher levels of carnitine

supplementation than a.8% (E3) did not further decrease total lipid
concentrations (Figure 22).

Plasma concentrations (mg/g) of

triglyceride showed a similar pattern as total lipids (Table 18
and Figure 22).

The concentrations of triglycerides were

significantly lowered by carnitine supplementation with the lowest
concentrations found in the E3 group.

Again, higher levels of

carnitine than a.8% did not further decrease triglyceride concentrations either (Figure 22).
Plasma concentrations (nmole/ml) of carnitine were elevated
in all the supplemented groups, and compared to the Ea group, the
elevation was statistically significant in the groups supplemented
with a.5% carnitine or more (E2, E3, E4, and E5) (Table 19 and
Figure 23).

The highest concentrations of plasma carnitine were

found in the E4 and E5 group (Table 19 .and Figure 23).

However,

the plasma concentrations of ASAC and AIAC were not significantly
altered by carnitine supplementation (Table 19 and Figure 23).
Among the supplemented groups, the highest concentrations of these
acylcarnitines were found in the E3 group (Table 19 and Figure 23).
Changes in total carnitine content showed a fairly similar pattern
as those of the carnitine content and were elevated in all carnitinesupplemented groups, and the elevations were statistically significant
in all the supplemented groups compared to the Ea group except for
E1 (Table 19 and Figure 23).

TABLE 18.

Effects of Various Levels of Carnitine on Plasma Concentrations of Total Lipid and Triglyceride
(Experiment III)

Parameters

Eo
----------------

Total lipids

81.43+1. 75c

TG

23.33+1.94C

Ez

E1

Grau
E3

E4

E5

------- ----------(mg/dl) ------------------------------------------------0

61. 43+5. 74ab

51.79+4.ogab

47.50+4.53a

58.57+6.ooab

67.14+5.9]bC

18.61+1.04ab

16.67+0.98ab

14.23+1.63a

17 .Ol+l.71ab

19 . 1O+ 1. 71 b

Note. The values are mean+ SEM for five animals. Values without a common superscript letter are
significantly different from each other (P<0.05). E =ethanol.

.......

a
a

-0
......
0.
......
,-,--

100

(tj

.µ

0

+,)
(tj

E

Vl

(tj

,-0.

40

,-O')

E

QJ

......

C:

5-

0
......

u

(tj

,--

+,)

5-

......

C:

5-

QJ

»

.µ

C:

-0

0

u

,2--.........

--2~f

40

O')

QJ

u

60

-0

Vl

.µ

80

-0
..........

C:

20
-•

t __ ut X

•

D

I'

X

T•

:rs:Tfllld

X

(tj

0 ~-------L------L--------------.....__ _ _ __
0 .1
0.4
0.8
1. 2
1.6

Supplementary levels of carnitine (%, W/W)

FIGURE 22.

Effects of various levels of supplementary carnitine on the plasma concentrations
(mean i.. SEM) of total lipid (-o-) and triglyceride (-x-) in ethanol-fed rats.
t---'

0
t---'

TABLE 19.

Effects of Various Levels of Carnitine on Plasma Concentrations of Carnitine (Experiment III)

Grau
Parameters

Eo

E1

E2

E3

E4

Es

------------------------------------------------(nmole/ml)-----------------------------------------CNE

34.57+6.68a

48.86+7.3sab

56.38+ 5_44b

69.43+5.41bc

80.48+3.58C

77.92+5.98C

ASAC

10.31+1.98a

11: 66+3. 26a

14.82+ 3_95a

I9.02+2.22a

16.49+4.Isa

I6.30+3.1la

AIAC

5.30+0.87a

6.15+1.25a

8.70+ 2.37a

9. 08+1. 46a

6. 36+1.0l a

8.60+0.87a

50.89+8.lSa

66.67+8.ooab

79.91+11.QJbC

97.53+7.52C

103.33+4.SJC

Total CNE

102. 83+ 7. 71 C

Note. The values are mean+ SEM for five animals. Values without a common superscript letter are
significantly different from each other (P<0.05). CNE = carnitine, ASAC = acid soluble acyl carnitine,
AIAC = acid insoluble acyl carnitine. E =ethanol.
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The difference in the concentration (mg/g) of hepatic total
lipids was not statistically significant between the Eo group and
the E1 group, but the concentration was significantly lower in the
other supple~ented groups (E2, E3, E4, and E5) compared to the
Eo group (Table 20 and Figure 24).

~he changes in hepatic trigly-

cerides showed a similar pattern as those of hepatic total lipids,
and the levels were significantly reduced in the supplemented groups
(except for the E1 group) compared to the Eo group (Table 20
Figure 24).

and

The lowest concentrations in both total lipids and

triglycerides were found in the E3 group (Table 20 and Figure 24).
Hepatic concentrations (mg/g) of both free and esterified cholesterol
did not significantly differ among groups, but those of total
cholesterol were significantly depressed in the E3 group compared
with other groups, Eo, E1, and E5 (Table 20).

The concentrations

(mg/g) of both phospholipids and free fatty acids in the liver were
not significantly altered by carnitine supplementation, but there
was a consistently increasing trend in.free fatty acid content with
increasing carnitine supplementation (percent increase:

4.58, 15.81,

18.96, 19.14, and 25.16 in E1, E2, E3, E4, and E5, respectively)
(Table 20).
Hepatic concentrations (nmole/g) of carnitine were significantly
elevated in all the carnitine supplemented groups compared with
those in the Ea group (Table 21 and Figure 25).

The changes in

the concentrations of hepatic ASAC showed a similar pattern as
carnitine and were elevated in all the supplemented groups compared

TABLE 20.

Effects of Various Levels of Carnitine on Concentrations of Hepatic Lipid (Experiment III)

Grou_es
Parameters

Ea

E1

E2

E3

E4

E5

------------------------------------(mg/g wet weight of liver)-------------------------------------Total lipids

69. 35+4. 11 C

61.41+4. 69C

46.41+4.oob

31.10+4. 25a

36. 51+1. 95ab

43.25+J.49ab

Triglycerides

31.61+2.67C

30. 41+2. asc

21. 86+2 . 73b

ll.45+2.s2a

12.23+2.07a

15:15+3.84ab

Free cholesterol

3.31+0.34a

3.27+0.1sa

2. 98+0.12a

2 .85+o.17a

3.07+0.07a

3.23+0.12a

Esterified
cho l es tero l

7.62+0.35a

· 7.40+0.s4a

7.30+0.48a

6.47+0.35a

7.21+0.24a

8.33+0.JSa

Total
cho l es tero l

10.93+0.46bC

10.67+0.S?bC

10.29+0.44ab

9.32+0.39a

10.28+0.26ab

11.57+0. 33c

Phospholipids

6.12+0.Joa

6.4o+o.sga

5.61+0.41a

s.12+0.s1a

5.85+0.64a

5.13+0.16a

ll.13+0.81a

11.16+0. 55a

12.89+0.4oa

13. 24+0. 75a

13.26+0.6oa

13.93+0.37a

Free fatty
·acids

Note. The values are mean+ SEM for five animals. Values without _a common superscript letter are
significantly different from each other (P<0.05). E =ethanol.
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TABLE 21.

Effects of Various Levels of Carnitine on Concentrations of Hepatic Carnitines (Experiment III)

Groups
Component

E2

E1

Eo

E3

E4

E5

---------------------------------(nmole/g wet weight of liver~--------------------------------------·
Carnitine

691.11 a
+ 79.20

1138.69b
+ 112 .09

1186. 26b
+ 111.15

1350.68b
.!. 53.06

1366.53b
+ 128.59

1069.40b
.!. 28.44

ASAC

215.97a
+ 56.66

+

584.98b
52.46

687.4ob
+ 37 .16

633.91b
+ 100. 57

569.90b
+
- 46.92

588.14b
.!. 59.22

AIAC

4.5oa
+0.56

Total
carnitine

862.26a
+101. 93

6.05bc
+ 0.23
1663.26b
.!. 78.11

-

5_54abc
+ 1.42
1941. 73bc
.!. 84.22

6.93c
.!. 0.%
1991.52c
+
- 46.32

4.89abc
+ 0.98
1941.32bc
+ 136.28

3.36a
+ 0.13
1660.89b

-+ 71.74

Note. The values are mean+ SEM for five animals. Values without a common superscript letter are
significantly different from each other (P<0.05). ASAC = acid soluble acyl carnitine; AIAC = acid insoluble
acyl carnitine.
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to the unsupplemented group (Ea).

However, changes in hepatic AIAC

were not consistent with concentrations being significantly increased
over the Eo group only in the E1 and E3 groups among the
supplemented groups (Table 21 an~ Figure 25).

The concentrations

of hepatic total carnitine content showed a consistent and
significant increase in all the supplemented groups, and the highest
concentrations were found in the E3 group (Table 21 and Figure 25).
The concentrations of total lipids in extrahepatic organs
such as kidney, skeletal muscle, and heart were not significantly
different (Table 22).

However, the concentrations of triglycerides

in some of the organs changed significantly with carnitine supplementation (Table 23).
changes were found:

Compared with the Eo group, the following
kidney showed significantly reduced concentra-

tions of triglycerides in E2, E4, and E5 groups, and those in
skeletal muscle were significantly lowered in the E3, E4, and E5
groups (Table 23).

No significant changes in the levels of

triglyceride content in the heart were.found among groups (Table 23).

TABLE 22.

Effects of Various Levels of Carnitine on the Concentrations of Total Lipid in Organs Other
Than Liver (Experiment III)

Grau
Parameters

Eo

E1

E2

E3

E4

E5

------------------------------------------(mg/g of wet weight)-------------------------------------Kidney
Skeletal
muscle
Heart

14.12+1.9la

13.94+0.42a

13.62+1.14a

13.67+2.17a

13.90+2.osa

11. 95+3. 2sa

8.09+1.84a

9.35+2.64a

10. 23+ 1. 56a

8.95+1.48a

9.12+1.61a

7.16+1. 39a

14.45+2.34a

13.70+2.76a

13.91+3.37a

11. 59+ 1. 6oa

13.30+0.56a

12. 53+1. 3sa

Note. The values are mean+ SEM for five animals. Values without a common superscript letter are
significantly different from each other (P<0.05). E =ethanol.

I-'
I-'

0

TABLE 23.

Parameters

Effects of Various Levels of Carnitine on the Concentrations of Triglyceride in Organs Other
Than Liver (Experiment III)

Eo

E1

E2

Grau
E3

E4

E5

--------------------------------------------(mg/g of wet weight)-----------------------------------11. 03+0. 36b

9.89+0.87ab

9.00+0.68a

9.67+0.6sab

8.76+0.54a

8.45+0.32a

Skeletal
muscle

5.56+o.ogc

5.6Q+Q.13C

5.53+0.2abc

4.34+0.2aab

3.89+0.38a

4.07+0.34a

Heart

6.54+0.27a

6.23+0.39a

6.19+0.37a

5.45+0.s1a

6.67+0.4oa

6.62+0.36a

Kidney

Note. The values are mean+ SEM for five animals. Values without a common superscript letter are
significantly different from each other (P<0.05). E = ethanol diet.

t-J
t-J
t-J

CHAPTER V
DISCUSSION
1.

EFFECTS OF CARNITINE AND ITS PRECURSORS ON TISSUE CONTENTS
OF LIPIDS AND CARNITINES
Ethanol feeding to rats at a level of 36% of the total calories

in the diet produced fatty liver and accompanying hypertriglyceridemia
(Tables 8 and 9, pages 78 and 80, and Figures 16 and 17, pages 79
and 81).

These results are consistent with the observations reported

in the vast amount of literature available on ethanol-induced fatty
liver (8,10,ll,13-16,30,38,99).

The concentration of total lipid

in chronically ethanol-compromised liver has been found to increase
approximately 115% (84.3 - 132.6 mg/g) over the normal liver
(41.0 - 58.0 mg/g) (8,10,30) which is in agreement with our results
where an increase of 60% (78.1.:. 9.5 mole/g) above the NE group
(48.6.:. 3.8 mg/g) was found.

The ethanol-induced increases in

hepatic triglycerides of about 21.8% (61.81.:. 11.46 vs 19.39.:. 6.05
mg/g) and in phospholipids, 38% (8.02 ±_ 0.59 vs 5.78 ±_ 0.50 mg/g)

observed in the current studies (Table 9, page 80) are also
comparable with literature values of a 691% increase (89.4.:. 11.1
vs 11.3.:. 1.3 mg/g), and 9% increase (31.4.:. 1.1 vs 28.8.:. 1.2 mg/g)
for triglyceride and phospholipid, respectively (37).

Similarly,

the 22% increase in hepatic free cholesterol (1.35.:. 0.07 vs 1.11 +
0.05 mg/g) and 50% increase in esterified cholesterol (8.56.:. 0.58 vs
112
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5.72 + 0.71 mg/g) found in the present studies are supported by
ethanol-induced increases reported in literature values such as 10%
elevation (2.2 ±_ 0.13 vs 2.0 ±_ 0.15 mg/g) in free cholesterol and
5-fold increase (2.92 + 0.14 vs 0.59
cholesterol (10).

.:t:_

0.05 mg/g) in esterified

The ethanol-induced increase in plasma triglyceride

of 66% (49.64 ±_ 9.92 vs 29.83 ±_ 3.45 mg/dl) was consistent with
reported literature values of a 97% increase (144 ±_ 9.9 vs 73

+

2. 1 mg/ dl ) ( 24) .
Supplementation of ethanol diet with 1.0% D,L-carnitine
significantly reduced the concentration of lipids in the livers
Table 9, page 80, and Figure 17, page 81) of alcoholic rats.

The

lipotropic effects of dietary carnitine were definitely evident
in the changes in total lipid, triglyceride, free cholesterol, and
phospholipid contents of the liver (Table 9).

The results are

consistent with the observations of Hosein and Bexton (24) who
reported a significant lipid lowering effect of tube-fed carnitine
(0.1 mg/g body weight) on rats; total l_ipids were reduced 19%
(from 77 ±_ 2.4 to 62 ±_ 4.4 mg/g) in livers of ethanol-fed rats
(6 g/kg body weight) by gastric intubation.

Lieber and DeCarli

(30) also demonstrated a lipotropic effect of dietary carnitine
(1.0 mg/cal) in rats on total lipids (114.5 ±_ 17.9 vs 132.6
mg/g) and triglycerides (34 ±_ 4.5 vs 39.5 ±_ 4.5 mg/g).

+

24.3

In the

present studies, the hyperlipidemia commonly associated with chronic
ethanol consumption was also minimized by carnitine (Table 8, page
78); these results are comparable with the decrease in plasma
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triglyceride (from 144 ±_ 9.9 to 111.0 ±_ 5.2 mg/dl) observed by
Hosein and Bexton (24) following carnitine treatment of ethanol-fed
rats by gastric intubation.

If the reduced hepatic and plasma lipid

contents in the carnitine supplemented group (Tables 3 and 9, pages
78 and 80) were due to depressed consumption of diet in this group
(Table 7, page 76), one would have expected the same effects in
the ELM and ECLM groups where food consumption (53.7 and 54.7 ml/day,
respectively) were akin to the EC group (54.6 ml/day).

The decrease

in hepatic total lipid or triglyceride contents were more closely
related to the hepatic carnitine contents than to the diet consumption
(Figures 17 and 19, pages 81 and 86, and Tables 9 and 11, pages
80 and 85).

In other studies also, animals given carnitine or other

supplements consumed identical quantities of diet but maintained
different concentrations of hepatic lipids (138).
The concentrations of carnitine and its species were monitered
to assess whether the lipotropic effect of supplemental carnitine
was due to increased tissue pool of car.nitine and acylcarnitine.
Hepatic carnitine and total carnitine concentrations were elevated
in both supplemented ethanol-fed groups (EC, ELM, and ECLM;
46.2 - 93.1%) and unsupplemented (E; 33.2%} group compared to those
in the NE group.

However, the concentrations of acylcarnitines,

especially the AIAC, were significantly increased only in the
supplemented ethanol-fed groups (E, EC, and ECLM) (Table 11, page
85).

Though the hepatic carnitine content of the supplemented

ethanol-fed group was not significantly greater than that of the
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NE group, it was akin to tha~ reported by Kondrup and Grunnet (25).
They reported increased hepatic concentrations of carnitine of 52%
(213

.:!:_

54 from 140

.:!:_

15 nmole/g); acetylcarnitine, 47% (203 .:!:. 31

from 138 + 42 nmole/g); and total CJ~n~tine, 47% (425 .:!:. 76 from
290

.:!:_

51 nmole/mg) in comparison of a carnitine-supplemented group

to a control group.
Thus, the question arises as to why the increased concentration
of carnitine in livers of the E group was unable to prevent hepatic
steatosis like was found in the supplemented groups.

Part of the

answer may lie in the formation of AIAC which was significantly
elevated only in the supplemented groups.

Perhaps the endogenously

pooled carnitine by liver was below the critical concentration needed
for exerting protective action and/or that this carnitine was being
concentrated for purposes yet to be discovered.
Prevention of fat accumulation in the livers of carnitine
supplemented ethanol-fed groups (Table 9, page 80) found in the
present study is supported by the obser.vations of Hosein and Bexton
(24).

They demonstrated a 18% decrease in total hepatic lipids

of carnitine treated rats compared to noncarnitine treated rats.
Also, observations in the current study lend support to the
carnitine deficiency hypothesis of Rudman et al. (23) in patients
with chronic alcoholic cirrhosis (in cirrhotic and noncirrhotic
patients, respectively, 36 .:!:. 4 and 78

.:!:_

9 µmole total carnitine

and 17 + 3 and 49 + 3 µmoles free carnitine/dl of serum).
Unfortunately, it can not be a simple classical deficiency of
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carnitine as may have been construed.

It is, however, possible

that there is a deficiency of functional carnitine i.e., a lack
of carnitine destined for acylation of fatty acids.
Precursors of carnitine, namely lysine and methionine also
reduced hepatic accumulation of lipid though these were not as
effective a~ the carnitine (Table 9, page 80).

These data are

comparable to observations of Lieber and DeCarli {30) in ethanolfed rats (36% calories as ethanol) where a significant lipid
lowering effect {69.6

.:!:_

4.9 from 105.3 .:!:. 14.6 mg total lipid/g liver)

of D,L-methionine (2.5 mg/cal) was observed.

Whether the effect

of lysine plus methionine was being mediated through endogenous
biosynthesis of carnitine from these precursors or by enhancing
lipoprotein secretion cannot be clearly determined from the current
study.

A part of the lipotropic effect in the ELM group may be

caused by methionine which is a known lipotropic agent (30) or by
lysine which is known to promote lipoprotein secretion in ethanoltreated 1 ivers (8).

It seems unlikely ·that lysine and methionine

exerted their lipotropic effect through additional biosynthesis
of carnitine, because the carnitine concentrations in the plasma
(Table 8, page 78) and livers (Table 11, page 85) of the ELM group
were not higher than those found in plasma and livers of the E
group.

Additionally, a combination of carnitine, lysine, and

methionine failed to produce an additive effect in reducing hepatic
lipid accumulation in alcoholic rats (Table 9, page 80).

The

presence of lysine and methionine with carnitine (ECLM) may even
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be interfering with the effect of carnitine (Table 9, page 80,
EC vs ECLM), since the lipotropic effect of the combination of all
three agents was lower than that of carnitine alone.

In the study

by Rudman et al. (23), administration of lysine-rich, methioninerich, and carnitine-free diet to the normal humans maintained normal
serum carnitine concentrations (55-103 µmole), but the identical
diet to cirrhotic subjects produced serum carnitine concentrations
only 25% of normal.

In another study (138), supplementation of

the basal diet with 0.42% lysine maintained hepatic concentrations
of carnitine close to those in the livers of rats fed 0.2% D,Lcarnitine diets.

These observations indicate that biosynthesis

of carnitine from the precursor, lysine was possible when the liver
was functioning normally.

The data reported in Table 11, page 85

of this study are only an indirect evidence that the biosynthesis
of carnitine from its precursors is impaired in the ethanol-compromised
liver since the concentrations of carnitine neither in plasma
(Table 8, page 78) nor in liver (Table·11, page 85) were significantly
increased in the ELM group over that of the E group.

It is very

possible that supplementary lysine and methionine did not reach
the liver in sufficient concentrations because the intestinal
absorption of amino acids is usually impaired by ethanol (139).
Since carnitine biosynthesis require cofactors like ascorbic acid,
pyridoxal, and niacin, their inadequate supply which is not
uncommon in alcoholic conditions may further cripple the biosynthetic
processes to produce carnitine (122).

There is also a possibility
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that the enzyme, 4-N-trimethyl-aminobutyraldehyde dehydrogenase
may compete for NAO+ against the alcohol dehydrogenase which may
be increased in alcoholic cases (124).

Definite evidence for

possible impaired carnitine biosynthesis in ethanol-compromised
liver must be provided by further research.
Ethanol-induced hypertriglyceridemia (Table 8, page 78, and
Figure 16, page 79) is closely related with hypocarnitinemia.
Supplementation of carnitine was effective in reducing the plasma
triglyceride concentrations close to those found in the plasma of
non-ethanol-fed animals (NE).

These data are supported by the

observations of Hosein and Bexton (24) who reported a reduction
in plasma triglycerides (111

.:!:_

5.2 from 114 .!. 9.9 mg/dl of plasma)

by carnitine in rats receiving ethanol (6g/kg body weight) by gastric
intubation as a 40% solution (W/V) in saline containing carnitine
to provide a dose of 0.1 mg/g body weight.

Also in another study

by Askew et al. (140) it was reported that 1.0% dietary D,L-carnitine
reduced serum triglyceride contents by ·21% (77.1 .!. 12.0 to 61.0 .!.
5.1 mg/dl) in non-ethanol-fed rats.

On the other hand, the precursors,

lysine and methionine failed to reduce plasma triglyceride
concentrations significantly, even though they were able to enhance
plasma concentrations of total carnitine significantly over that
of the E group (Table 8, page 78, and Figure 16, page 79).

The

hypolipidemic effect of a combination of all three agents (carnitine,
lysine, and methionine) was inferior to that of carnitine.

Like

in the case of liver, it seems that the presence of lysine and
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methionine with carnitine interferes with the hypolipidemic effect
of carnitine (Table 8, page 78, EC vs ECLM).

Reduced concentrations

of plasma carnitine in the E group (Table 8, page 78) may be ascribed
to confiscation of carnitine by the livers of these rats (Table 11,
page 85).

In other words, elevated concentrations of carnitine

in the alcoholic liver (E) (Table 11, page 85) may be at the cost
of plasma carnitine and perhaps the other extrahepatic tissues.
It can be argued that the lipotropic effect of carnitine
is due to transformation of carnitine to acylcarnitine, thus, consuming the fatty acid pool which is known to increase in chronic
ethanol consumption.

However, such a simple explanation can be

only a part of the total answer because the increases in acylcarnitines
in the liver were too small to affect the large magnitude of decrease
in hepatic lipid contents in the supplemented ethanol-fed groups
(Tables 9 and 11, pages 80 and 85).

In addition, the consistently

high concentrations of free fatty acids in the livers of these
groups does not concur with this idea.· Therefore, while a partial
contribution made by acylcarnitine formation may not be entirely
disregarded, it would be reasonable to say that carnitine mediates
a lipotropic effect via some other mechanisms which need to be
investigated.
The lipotropic effect of carnitine in alcoholic fatty liver
must be evaluated in comparison with that of some of other dietary
agents reported by other investigators.

Stanko et al. (22) reported

that chronic ethanol consumption (33% of calories as ethanol) caused
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a significant increase in the concentrations of triglyceride (67 ±_
7.5 vs 22.7 ±_ 2.5 mg/g) and supplementing the ethanol diet of rats
with a combination of pyruvate (22 g/500 ml of diet), dihydroxyacetone (22 g/500 ml), and riboflavin (2.2 g/500 ml) significantly
lowered (56.7%) the triglyceride concentrations (29 ±_ 3.2 vs
67 ±_ 7.5 mg/g) in the livers of ethanol-treated rats fed high fat
(35% of total calories) diet.

Goheen et al. (120) demonstrated

the beneficial effect of arachidonate for chronic cases.

In their

study, administration of ethanol to rats (34% of dietary calories
as ethanol; 35%, as fat) increased the hepatic concentrations of
triglyceride 10-fold (68.4 ±_ 6.37 vs 7.01.:::. 0.02 mg/g).

Replacing

part of fat in the diet with arachidonate (7% of the fat, W/V)
decreased triglyceride contents by 50% (27.56 ±_ 4.34 vs 68.4 + 6.37
mg/g).

This effect was also observed in phospholipid contents

(19.4 ±_ 2.4 vs 23.1 ±_ 1.3 mg/g).

Thus, compared to these dietary

agents, carnitine is as good a lipotropic agent as these compounds
in preventing ethanol-induced fatty liver.
No significant effects of dietary carnitine on changes in
lipids in organs other than liver were observed (Tables 12 and 13,
pages 88 and 89).

These results seem reasonable because metabolism

of both ethanol and lipid occurs primarily in the liver.

From this

phase of the study, it can be concluded that dietary carnitine,
and to a lesser extent lysine plus methionine, are effective in
preventing accumulation of lipids in the livers of rats chronically
fed ethanol.

The lipotropic effect of the supplementary carnitine
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may be due to increased fatty acid acylation perhaps increased
S-oxidation of fatty acids and even elimination of acylcarnitines
in urine.

It is hypothesized that a state of functional carnitine

deficiency exists in chronic ethanol-fed rats.
2.

DOSE-RELATED EFFECT OF DIETARY CARNITINE

In order to substantiate the lipotropic effect of supplementary
carnitine, it was deemed necessary to establish a dose dependent
response in chronic alcoholic rats.

To provide this information,

two consecutive experiments (Experiment II and III) were carried
out.

In the first experiment (Experiment II), it was not possible

to demonstrate significant effects of dietary carnitine levels on
ethanol-induced accumulation of hepatic fat.

Although the differences

were not statistically significant, there was a definite trend.
The concentrations of plasma triglyceride were consistently decreased
with increasing levels of carnitine supplementation (Table 15, page
92, and Figure 20, page 93).

Similarly, the concentrations of both

total lipid and triglyceride in liver were progressively reduced
with the increasing levels of supplementary carnitine except for
the highest level (2.0%) (Table 16, page 95, and Figure 21, page 96).
The 2.0% level of supplemental carnitine showed less lipotropic
effect than the 1.0% carnitine level.

This established the higher

limit of supplementation which will result in effective lipotropic
action.
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A second dose response experiment (Experiment III) was
carried out at range of doses different than those used in the
Experiment II with more mature animals and for a longer period of
treatment.

The reasons for designing this stud} was based on

the assumption that the insignificant effects of carnitine found
in Experiment II were due to a shorter experimental period which
might be insufficient to cause a significant effect and that the
animals were younger in age than those used in other alcohol experiments.

The results of this experiment established a definite dose-

dependent response of carnitine.

Various levels of carnitine

progressively and significantly decreased the hepatic and plasma
lipid concentrations and were well related with the changes in
carnitine pools.

Concentrations of lipids (mainly total lipid and

triglyceride) were decreased with increasing concentrations of
carnitine in both plasma and liver.

This relationship (inverse)

between concentrations of lipid and carnitines was more obvious
when the results were plotted by using .the quantities of changes
in the values as independent variables instead of the values as
shown in Figures 26 and 27.

It can be seen from these figures that

the peak decreases in both total lipid and triglyceride were
associated with peak increases in carnitine concentrations
(especially in carnitine in plasma and in total carnitine and
AIAC in liver).

These peak increases and decreases occurred,

primarily, in the group getting 0.8% D,L-carnitine.

The highest

concentration of hepatic total carnitine was found in the E3 group
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(Table 21, page 107), and conversely, the lowest concentrations
of various lipids (total lipids, triglycerides, free cholesterol,
total cholesterol, and phospholipids) in liver were found in the
same group (Table 20, page 105).
In both Experiment II and III, the lipotropic effect was
reduced at levels higher than 1.0% carnitine.

The mechanisms involved

in the reduced lipotropic effect should be assessed by further
research.
levels.

It may be due to inherent toxicity of carnitine at high
This may also be due partly to saturation of carnitine

in esterification to form acylcarnitine in connection of B-oxidation.
In fact, the concentrations of acylcarnitine in the livers of
animals receiving carnitine at levels higher than 1.0% was no greater
than those seen in the livers of rats receiving 0.8% of carnitine
(Table 20, page 105).

It is possible that at higher supplementary

levels, there was reduced absorption of exogenous carnitine.

No

doubt at carnitine supplementary levels higher than 1%, the
concentrations of both hepatic and plasma carnitines were decreased
compared to those found in the E3 group (Tables 19 and 21, pages
102 and 107).

Also there are some indications (141) that 0-carnitine

may exert a negative effect at high levels on the availability of
exogenous L-carnitine and, therefore, on its function as well.
From the observations, it can be concluded that the lipotropic effect of dietary carnitine in alcoholic rats is doserelated with the optimal level of dietary supplementation being
0.8% carnitine.
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The overall conclusion is that dietary carnitine is an effective
agent for amelioration of ethanol-induced fatty rat liver, and the
effect is dose-related with the optimal level being 0.8% carnitine
in the diet.

CHAPTER VI
SUMMARY
The effect of dietary carnitine and its precursors of
ethanol-induced fatty liver and hypertriglyceridemia was examined
in an animal model.

Consistent with the observations in the

literature, ethanol fed at 36% of total calories to rats produced
a significant increase in hepatic concentrations of total lipids,
triglycerides, phospholipids, and free and esterified cholesterol
as well as elevated plasma concentrations of triglycerides.

The

elevation of liver lipids occurred despite increased concentrations
of hepatic carnitine which is incongruent with its lipotropic
potential.

Thus, endogenous carnitine was either quantitatively

and/or qualitatively inept in ameliorating fatty liver.
It was only when the ethanol diet was supplemented with
D,L-carnitine that there was a significant reduction in the
accumulation of lipids in the ethanol-compromised liver.

The

lipotropic effect of the same magnitude did not occur when the
diet was supplemented with lysine and methionine despite the fact
that hepatic carnitine concentrations were further elevated.
Thus, the lipotropic effect was exerted only by exogenously
supplied carnitine.

From these results, it appears that a

functional carnitine deficiency exists in chronic alcoholic rats
and only exogenous carnitine can ameliorate this condition by
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perhaps increasing the endogenous pool of carnitine to a state
facilitating acylation of fatty acids; thus, removing them by
S-oxidation or excretion in the urine.

On the other hand, there

may be more than one pool of carnitine with dietary carnitine
belonging to the functional pool.
Precursors of carnitine, lysine, and methionine were about
82% effective as carnitine in lowering ethanol-induced accumulations
of hepatic fat.

This effect may be mediated by methionine which

is a known lipotropic agent or by lysine which is a promoter of
lipoprotein secretion.

However, it is unlikely that the observed

lipotropic effect was due to new biosynthesis of carnitine from
these precursors because the concentrations of carnitine in both
plasma and liver were not significantly increased in the Lys and
Met supplemented group.
The impaired biosynthesis of carnitine from the precursors
may be due to either inadequate supply of cofactors like ascorbic
acid, pyridoxal, and niacine, or due tcr unfavorable competition for
the NAO+ by 4-N-trimethyl-aminobutyraldehyde dehydrogenase against
alcohol dehydrogenase, the activity of the latter is usually
increased in alcoholic cases.

However, definite evidence for im-

paired carnitine biosynthesis must be followed by further research.
The effect of a combination of carnitine, lysine, and
methionine was no greater than that of carnitine alone.

The presence

of lysine and methionine with carnitine seems even to interfere
with the effect of carnitine.
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Dietary carnitine was also effective in ameliorating ethanolinduced hypertriglyceridemia.

However, like in the case of liver,

the hypolipidemic effects of combinations of either lysine and
methionine or carnitine, lysine, and methi0nine were inferior to
that of carnitine.

Similar to the observations in liver, the

presence of lysine and methionine with carnitine seemed to interfere
with the hypolipidemic effect of carnitine.
The dose response for dietary carnitine was established in
mature rats over a seven week period.

The concentrations of total

lipid and triglyceride were significantly and progressively reduced
and those of carnitine were significantly increased with increasing
levels of dietary carnitine supplementation up to 0.8% in both
liver and plasma.

Thus, there is a definite inverse relationship

between the concentrations of lipid and carnitine in both liver
and plasma.

The highest concentrations of total carnitine and the

lowest concentrations of various lipids in liver were found in the
animals receiving 0.8% carnitine.

The .lipotropic effect of

carnitine was reduced at levels higher than 1.0% supplementation.
This may be due to inherent chemical nature (toxicity) of carnitine
at high levels, saturation of the esterification process, reduced
intestinal absorption of carnitine, or a negative effect of racemic
isomers on availability of L-carnitine.

Further research

is needed to assess the definite mechanisms involved in the reduced
lipotropic effect of carnitine over 1.0% supplementation.

From
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these observations, it is concluded that carnitine is an effective
lipotropic dietary nutrient and its effect is dose dependent.
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